Concall Notes.
Short editorial briefs on Indian earnings calls. Transcript notes are written from call transcripts; call-monitor notes use Tijori Concall Monitor analysis, credited clearly.
Where management changed its story
Calls where this quarter's guidance appears to contradict a prior call. Source: Tijori Concall Monitor's consistency check, summarised editorially.
-
Basilic Fly Studio's pipeline is rocketing, but its credibility is not
Repeated delays on receivables, missed Bengaluru headcount, and reframed margin contraction raise questions about execution reliability.
Inconsistency Receivables recovery timeline pushed from March-May 2025 to late 2026; Bengaluru headcount target of 50+ by end-FY26 missed (actual 30) yet called 'ahead of schedule'; margin contraction reframed as 'planned temporary compression' after earlier guidance to restore subsidiary margins.The pipeline is rocketing, but the execution narrative needs a landing.
-
CMR Green Tech's volume math doesn't add up: 80,381 MT vs implied 408,000 MT
A critical metric for modeling—FY26 volume—was reported as 80,381 MT, but the same call's per-ton profit numbers point to a far larger figure. The contradiction was left unexplained.
Inconsistency In the Jul 2026 call, the Director of Business Development stated FY26 volume as 80,381 MT, but the CFO's per-ton PAT of ₹5,580 on ₹228 cr PAT implies volume exceeding 408,000 MT—a >5x discrepancy. Management did not explain the conflict.CMR's numbers don't match. Investors need a clean explanation before the growth story can be underwritten.
-
Adisoft inflated order book on the same call, then corrected itself
Management first guided order book at ₹96.32 cr, then admitted that figure includes unconfirmed pipeline. The real order book: ₹38.54 cr.
Inconsistency In the Jun 2026 call, management initially stated the order book was ₹96.32 crores and would be executed in FY27. Later in the same call, when pressed, they said that figure is an 'order pipeline' and the actual firm order book is ₹38.54 crores. The contradiction was not explained.Adisoft's growth story works — but the order book confusion on a single call makes every number harder to trust.
-
Patel Retail's Q4 revenue growth changed from 53.35% to 5.35% between two disclosures
In the same quarter, management declared 53.35% YoY growth in one statement and 5.35% in another. The gap is unexplained and underscores a broader pattern of strategic pivots without clear rationale.
Inconsistency In the prior Jun 2026 call, management said Q4 FY26 total income grew 53.35% YoY to ₹339.55 cr. In the latest Jun 2026 call, the same metric was stated as 5.35% growth to the same revenue figure. Management did not address the discrepancy.Patel Retail's revenue growth flipped from 53.35% to 5.35% between two calls in the same month. Credibility is the first casualty.
-
Pajson Agro's growth guidance and sourcing story flip in one month
Management cut base facility growth outlook from 20-22% to 15%, reversed stance on Dubai group dependency from 96% to 30%, and contradicted geopolitical supply chain impact without explaining the shifts.
Inconsistency Management made three contradictory statements between May and June 2026: (1) Geopolitical tensions had no supply chain impact in May, but in June they admitted previous disruption. (2) In May, 96% raw material from Dubai group company was 'business as usual', but June claimed it had already dropped to 30%. (3) Base facility growth guidance was cut from 20-22% to 15% without explanation.Pajson Agro's capacity story is real, but the guidance reversals erode trust. Bridges, not just numbers, are needed.
-
Captain Polyplast extends 50:50 mix timeline, revises capacity target without explanation
The company pushed back its solar EPC mix goal to three years after accelerating it to two, and claimed manufacturing capacity can now support ₹600 cr vs. ₹400 cr previously — but offered no bridge.
Inconsistency Management extended the target for a 50:50 revenue mix between micro-irrigation and solar EPC back to three years, reversing the acceleration to two years stated in the May 2026 call. Additionally, the claimed micro-irrigation revenue capacity jumped from ₹400 cr to ₹600 cr without explanation.Strong growth, but two unexplained guidance reversals make the forward view harder to trust.
-
AVG Logistics cut its liquid fleet target and warehousing space — without explanation
Q4 EBITDA margin surged to 19.66% and a Haldiram contract was signed, but two guidance reversals raise questions about management's consistency.
Inconsistency In Feb 2026, AVG planned to add 5-6 liquid logistics trains next year; in Jun 2026, it reduced the target to one rake. Warehousing space dropped from ~9 lakh sq ft to 7.41 lakh sq ft. Neither shift was explained.AVG's numbers look healthy, but unexplained strategy shifts make its guidance harder to believe.
-
Prevest Denpro's 3D printer launch date shifted 19 months — and management didn't explain why
CEO said in May 2025 the printer was 'very soon' and not yet commercial; 13 months later he claimed sales began in November 2024, a contradiction that muddies the 162% growth figure.
Inconsistency In May 2025, CEO Dr. Sai Kalyan said the 3D printer was 'not yet commercially launched' and only sample pieces were out for market testing. In June 2026, he claimed the company started selling 3D printers in November 2024 — a retroactive shift of the launch date by at least 18 months. No explanation was offered for the discrepancy.Prevest Denpro's numbers are real, but its timeline on 3D printers isn't. That's a credibility gap that needs bridging.
-
Rathi Steel's cost savings guidance plunged from ₹3,000-4,000/ton to ₹1.5-2/ton
In the same month, management first guided massive savings from hot charging, then slashed to near zero. Capacity expansion plans were also reversed.
Inconsistency Management first guided cost savings of ₹3,000-4,000 per ton from hot charging in TMT mill, then at a summit said savings would be just ₹1.5-2 per ton. Similarly, earlier they evaluated expansion of steel melting shop, later said no capacity expansion plans beyond maintenance.Rathi Steel's turnaround story needs a consistent script. This quarter it got two different ones.
-
Khazanchi posted a record profit but guided sharply lower on its flagship showroom
PAT nearly doubled to ₹89.42 cr but flagship showroom FY27 guidance collapsed from ₹500-550 cr to ₹125-150 cr, and B2C retail timeline slipped by a year.
Inconsistency In Feb 2026, management guided for ₹500-550 cr from the flagship showroom in FY27. In Jun 2026, that target was cut to ₹125-150 cr, or 25-30% of the original. Separately, the timeline to reach 25% B2C retail contribution was pushed from 1-1.5 years to 2-3 years. Both shifts lack detailed explanations.Record profit, but the guidance cuts and fundraising flip knock the shine off a sparkling year.
-
Maiden Forgings' defence revenue target quadrupled in six months without a catalyst
In June 2026, management said B2G will be 60-70% of revenue in 2-3 years, up from 10% in November 2025 and 20-25% just weeks earlier. No new orders cited.
Inconsistency B2G revenue guidance has swung from 10% (Nov 2025) to 20-25% (early Jun 2026) to 60-70% (late Jun 2026) over nine months, with no explanation of the underlying orders or contracts that justify a business model pivot.Maiden Forgings' defence target is six times its earlier guidance, and the market has no evidence it's real.
-
Persistent buys Nagarro for €1.27bn in a debt-fueled pivot from its organic-only strategy
Persistent announced an acquisition of Nagarro, doubling its size and expanding European exposure from 8.5% to 22%, while contradicting its earlier stance on capital allocation and margin definitions.
Inconsistency In January 2026, management stated organic growth and consistent dividend payout. In June 2026, it announced a €1.27bn debt-funded acquisition of Nagarro with a 140% premium. Additionally, in April 2026, it reported EBIT margin of 15.6%, but in June it called the same figure EBITDA margin.Persistent's Nagarro buy is a bold strategic bet. The debt, the premium and the pivot from organic all merit scrutiny.
-
Astral demerger justified by reversing its own brand synergy strategy
Management told investors in August 2025 that unifying under the Astral brand was a 20-year plan to cut ad costs. Now it says there is no commonality in branding — the exact opposite reason to justify splitting the company in two.
Inconsistency In August 2025, management said the unified Astral brand was a deliberate 20-year strategy to minimise advertising costs and cross-leverage the plumbing brand. In June 2026, to justify the demerger, it said there was 'no commonality in branding' and that the chemical business needed to step out of the pipe division's shadow. The contradiction is not acknowledged.Astral's demerger logic and CPVC timeline both rely on a version of history that the company's own past guidance contradicts. Credibility is the missing piece.
-
Univastu offered conflicting explanations for finance cost drop in same call
Order book hit a record ₹1,854 cr (2x book-to-bill), but management first attributed lower finance costs to operational discipline, then admitted it was from equity dilution—a contradiction that undermines transparency.
Inconsistency In prepared remarks, Univastu's CFO said lower finance costs came from tight fund management and timely recoveries. Later in Q&A, he admitted the reduction was driven by cash inflows from preferential shares and warrants, not operational improvements.Univastu's order book is bulletproof. Its explanations need to be too.
-
Denta Water slashes FY27 guidance: revenue 20%, margin 22-25%
In its June 2026 concall, the company lowered revenue growth guidance from a previously projected 30% to 20% and EBITDA margin target from 30%+ to 22-25%, while delaying working capital liquidation by a quarter.
Inconsistency Management reversed three key guidance items: (1) FY27 revenue growth cut from 30% to 20% without explanation; (2) EBITDA margin target reduced from 30%+ to 22-25%, attributed to project mix and raw material costs; (3) working capital liquidation delayed from 'coming quarter' to December-January. None of the prior projections were explicitly retracted.Denta Water's credibility is the quarter's biggest casualty. Numbers matter more than guidance now.
-
Viviana Power Tech's real estate subsidiary was a 'collateral' move. Now it's a ₹370 cr developer.
Nine months after minimizing Viviana Lifespace as a banking tool, management reveals two active Vadodara projects worth ₹370 cr, alongside an accelerated ₹100 cr transformer capex.
Inconsistency In Sep 2025, management said the real estate subsidiary was only for creating bank collateral. In Jun 2026, it revealed two projects worth ₹370 cr under development. Similarly, a transformer capex timeline of 1-1.5 years was compressed to a ₹100 cr greenfield plant within 9 months.Viviana's numbers are strong, but two strategy pivots in nine months make the roadmap harder to trust.
-
Dhruv Consultancy's accounting guarantee lasted one quarter
Order book hits Rs 600 crore and Q1 intake Rs 100 crore, but management's broken promise on no further adjustments and a pivot to asset-heavy BOT raise credibility questions.
Inconsistency In Mar 2026 management guaranteed no further accounting adjustments after Q3's one-time revision. In Jun 2026 it admitted further corrections caused another quarterly loss. Separately, the firm pivoted from an asset-light consultancy model to a BOT wayside amenity requiring direct capital investment and debt.Order book strong, but broken accounting guarantees and an asset-heavy pivot mean the story now needs proof, not promises.
-
Esconet gave two different PAT figures in same call, no explanation
Consolidated PAT for FY26 was stated as ₹12.25 cr early in the call and later as ₹6.16 cr, a 50% gap management did not address
Inconsistency In the June 2026 call, management first said consolidated PAT for FY25-26 was ₹12.25 crores, then later reported it as ₹6.16 crores without any explanation for the discrepancy.Esconet's growth story is compelling, but a 50% PAT gap in the same call demands an answer.
-
Steel Exchange India slashes FY27 volume target after doubling promise
Management guided 25-35% volume growth in June from a doubling target agreed in May, even as CRDA approval and reheating furnace create new capacity.
Inconsistency In May 2026, management agreed with an analyst's projection that FY27 sales volumes would double year-on-year. In June 2026, they guided for 25-35% volume growth, without explaining the dramatic revision. Prateek Shrivastava: 'So that is for the full year, FY27, we are saying we'll double the volumes.' Bandi Suresh Kumar: 'Yes.' Latest call: expected volume growth between 25-35%.The Amaravati opportunity is real, but a guidance flip this size erodes trust. Delivery will matter more than promises.
-
Knowledge Marine delays green tug deployment to 2028-2029; fleet doubles
Green tug deployment pushed by at least one year from mid-2027 target; record revenue and margins as fleet hits 100% utilization across 45 vessels.
Inconsistency In the June 2026 call, management guided that green tugs would be fully constructed by mid-2027. Later in the same call, they stated deployment by 2028-2029, without explaining the multi-year delay.Knowledge Marine's fleet growth is impressive, but the unexplained green tug delay undermines credibility on execution timelines.
-
Jyothy Labs ended Pril and Fa licenses weeks after affirming both brands' future
Management told investors in May it would invest in both Pril and Exo dishwash brands; by June 1 it had halted all Pril operations, shifting focus solely to Exo.
Inconsistency In the May 2026 call, management said: 'we wish to see that both the brands grow, we'll be investing on both the brands.' In the June 2026 call, management revealed they had been in exit negotiations for months and abruptly ceased all operations for Pril on June 1, shifting sole focus to Exo.Jyothy's guidance credibility took a hit with the Pril exit. The strategy reversal needs a better explanation than arbitration logistics.
-
Kotyark capacity numbers don't match: 1,500 vs implied 533
In its June concall, Kotyark's prepared remarks claimed Rajasthan capacity rose to 1,500 KLPD. Q&A revealed a 75% increase from current levels implies a baseline of ~533 KLPD. The gap matters for utilization targets.
Inconsistency In the prepared remarks, management said Rajasthan capacity was expanded from 500 KLPD to 1,500 KLPD during FY26. But in Q&A, they said adding 400 KLPD of new capacity would represent a 75% increase from current levels — mathematically implying a current baseline of ~533 KLPD, not 1,500. The discrepancy was not addressed.Kotyark's growth story rests on capacity it can't keep straight. The numbers need to add up before the utilization thesis does.
-
Maiden Forgings slashed revenue target 25% without explaining the math
The revenue potential of the expanded plant was cut from 700-800 cr to 550-600 cr, while the MD admits a 'mindset problem' after blaming macro factors.
Inconsistency Maiden Forgings cut its peak revenue guidance for the 62,000-ton capacity from 700-800 cr (Nov 2025) to 550-600 cr (Jun 2026), despite assuming a 30% stainless steel mix. The company also said in Nov 2025 it was actively raising funds, but in Jun 2026 claimed no equity or debt raised in two years.Maiden Forgings' capacity math doesn't add up. The new numbers are credible only after an explanation — which wasn't given.
-
Shri Balaji Valve's customer concentration jumps to 60-65% without explanation
The company also downgraded its new facility from 'initiated capex' to 'brainstorming' – two material reversals that cloud an otherwise solid growth story.
Inconsistency Customer concentration surged from about 35% to 60-65% for top five customers between the Jan 2026 and Jun 2026 calls, with no explanation. Separately, the new facility development was described as 'initiated' in January but downgraded to 'brainstorming' in June.Solid growth, two unexplained pivots – investors need a why before underwriting the story.
-
HPL Electric's debt reversal undermines a solid dual-engine quarter
Management now says debt will stay stable, not falling, contradicting its Nov 2025 pay-down pledge. FY26 revenue crossed ₹1,800 cr and smart meter orders hit ₹3,200+ cr.
Inconsistency In Nov 2025, management said net cash flows would reduce short-term working-capital debt. In Jun 2026, it reversed: debt levels will remain at current levels, relying on revenue growth to improve the ratio. The pivot was unexplained.HPL Electric's dual-engine growth is real, but its debt repayment reversal creates an unexplained credibility overhang.
-
Ecoline Exim says shipping is stabilising, then says it's worsening — both in the same call
Management's prepared remarks claim geopolitical conditions easing, but Q&A reveals shipping times increasing and working capital under pressure. The contradiction undermines a confident backpack pivot story.
Inconsistency In June 2026, Ecoline's MD Saurabh Saraogi opened the call saying 'shipping lines are stabilizing, geopolitical conditions are easing'. Later, when asked about working capital, he said 'with shipping times increasing, our payment cycle is being impacted. Due to the ongoing conflict, shipping times have risen.' Two conflicting assessments of the same macro reality, minutes apart.Ecoline's backpack plan is ambitious. The same-call contradiction on shipping makes it harder to trust the timeline.
-
Coforge's management says it announced a government business closure. It didn't.
CEO Sudhir Singh claimed the May 2025 call flagged a $50M government exit. The transcript shows the opposite: the business was being 'built up painstakingly.'
Inconsistency In the Jun 2026 call, management claimed they announced in May 2025 that a poorly performing government business would be closed or hived off. But the May 2025 call transcript shows management said: 'Our government business outside India and our healthcare business is being built up painstakingly following the exact same approach.' The two statements contradict directly.Strong execution numbers, but the credibility gap between what management says and what the record shows is narrowing.
-
RBM Infra cut its FY27 revenue target by half. It's not the first broken promise.
Six months after guiding for ₹1,000-2,000 crore in FY27 revenue, management now targets ₹700 crore. The main board migration and a railway order have also been delayed or derailed.
Inconsistency Management cut FY27 revenue guidance from ₹1,000-2,000 crore to ₹700 crore, delayed main board migration from January/February to 20-25 days out, and revealed that a railway order previously expected within 15 days is now on hold and undergoing rebidding.RBM Infra's operational execution is impressive. Its guidance credibility is not.
-
Namo Ewaste contradicted itself on battery sourcing in the same call
Management first said batteries came mostly from IT, e-commerce and manufacturing OEMs, then said 70% came from auto and 30% from consumer durables — no explanation for the flip.
Inconsistency Early in the Jun 2026 call, management said hazardous battery waste was sourced mostly from IT, e-commerce and manufacturing OEM clients. Later, they claimed corporate battery supply was 70% from automobile and 30% from consumer durables, completely omitting the earlier segments. The contradiction was not addressed.Namo Ewaste's growth story is real; the sourcing contradiction is a small crack that deserves an explanation before it widens.
-
Monolithisch India's margin guidance contradicts itself within same call
Management first guided flat FY27 EBITDA margins, then confirmed a 4-4.5% improvement from premium product migration — a flip-flop that undermines credibility.
Inconsistency In the Jun 2026 call's opening remarks, management guided for 'similar levels of EBITDA margins' in FY27. Later, they confirmed a 4-4.5% EBITDA improvement from SGB Limited premium product migration, admitting the flat guidance was 'just an arbitrary conservative base.' Similarly, the greenfield plant delay was first attributed solely to a 15-20 day LPG crisis, but Q&A revealed a 1.5-2 month halt from Bengal elections as the primary cause.Monolithisch has a good business story. The margin flip-flop means investors have to wait for proof.
-
Rox Hi-Tech contradicted itself on revenue and margins in the same call
Management first reported double-digit FY26 revenue growth, then agreed revenue fell. It also accepted both margin dip and margin expansion explanations.
Inconsistency In the Jun 2026 call, management first reported 11.33% YoY revenue growth, then later agreed revenue declined due to supply delays. For margins, they simultaneously attributed a dip to higher costs and credited margin improvement to internal efficiency.Rox Hi-Tech's growth story is promising, but its contradictory revenue and margin statements make FY27 guidance hard to underwrite.
-
Shree OSFM bought 75 vehicles to fulfill DRHP commitment, not client mandate
Management first said the purchase was needed to keep a client mandate. Later admitted there was no compulsion — it was to satisfy an IPO promise.
Inconsistency In the Jun 2026 call, management first justified buying 75 vehicles by claiming it was a client requirement to avoid losing business. Later in the same call, they admitted there was no client compulsion and the purchase was only to fulfill DRHP commitments. Additionally, they stated a pan-India fleet of 3,200 vehicles with buses at 7-8% (max 256), but also claimed 500 buses in the FlixBus partnership alone.Shree OSFM's contradiction on vehicle purchases undermines trust. The growth story is on hold until the numbers and the narrative line up.
-
Bai-Kakaji management gave two different FY25 revenue figures on the same call, an ₹100 cr gap
In its concall, management first said FY25 revenue was ₹225 cr, then later said it was ₹325 cr. The discrepancy distorts all YoY comparisons and raises a flag on data reliability.
Inconsistency Within the same earnings call, management first stated FY25 revenue as ₹225 cr (with PAT ₹18 cr), then later said it was ₹325 cr when comparing with FY26's ₹365 cr. The ₹100 cr variance completely alters the reported 12.3% growth rate and undermines the credibility of the financial narrative.The ₹100 crore revenue discrepancy in one call overshadows a genuinely improved balance sheet. Investors should demand a corrected filing before underwriting the growth story.
-
MP Bharat Agro's 150% capacity expansion came with a 40% capex overrun
Record FY26 PAT of ₹150 cr and 60-70% FY27 growth guidance are overshadowed by three strategy reversals that raise questions about management's reliability on capex, trading, and working capital.
Inconsistency Management contradicted itself on three fronts: capex guidance (October 2025: ₹700 cr; June 2026: ₹1,000+ cr, a 40% overrun), trading activity (May 2025: limited internal use; June 2026: major revenue driver depressing margins), and working capital improvement (May 2025: promised improvement; June 2026: reported negative operating cash flow).MP Bharat Agro's growth story is real, but three strategy flip-flops undermine trust in management's numbers.
-
Avanti Feeds reversed stance on US tariff refunds: now expects $15-20 million
Six months ago management said refunds would go to customers. Now it says it will keep $15-20 million as importer of record, with no explanation.
Inconsistency In November 2025, management said they did not expect to retain US tariff refunds because costs were passed to customers. In June 2026, they said they are the importer of record and expect a $15-20 million refund directly. No explanation for the reversal.Avanti's refund pivot adds a credibility question to an otherwise solid export story.
-
Arisinfra's DAAS story shifted in a month: pipeline shrinks, working capital claim reverses
June call says DAAS needs no working capital and manages ₹1,500 cr GDV – both contradict May statements by the same management.
Inconsistency In the May 2026 call, management said DAAS requires small working capital infusions. In the June 2026 call, they said it is completely asset-light with no working capital requirement. Separately, the DAAS pipeline dropped from ₹1,800+ cr to ₹1,500 cr in a month, unexplained.Arisinfra's FY26 numbers are strong. But the DAAS pipeline and working capital flip-flops make the guidance harder to underwrite.
-
Jinkushal cuts revenue target, reverses geographic expansion plan
Revenue target lowered to ₹600-700 cr from ₹800 cr, PAT margin guide cut to 5-7% from 7-9%, and new geography entry shelved, all without management acknowledging the changes.
Inconsistency In Oct 2025, management guided for ₹800 cr revenue in 2-3 years and 7-9% PAT margins, and in Feb 2026 said it was entering new geographies. In Jun 2026, the revenue target dropped to ₹600-700 cr, PAT margin target to 5-7%, and geographic expansion was shelved, with management claiming targets were unchanged.Jinkushal's expansion story is real, but its guidance revision problem is too.
-
Health X reverses capital stance, now raising ₹154 cr debt after denying need
Management said no external capital needed for 5 years; now taking bank loans for warehouse. Also admitted JITHO transition hurt branded sales after denying any conflict with generic products.
Inconsistency In Nov 2025, management said no external capital needed for 5 years, citing ₹400 cr treasury. In Jun 2026, it announced ₹154 cr in bank loans for warehouse expansion. Separately, in Feb 2026 it said no conflict between generic JITO and branded medicines, but in Jun 2026 it blamed JITHO transition for muted growth due to disturbance in branded sales.Health X's operational turnaround is real, but the credibility gap on capital and channel conflict needs bridging.
-
HOEC reverses HPCL crude sale strategy, pledges three-year production ramp
Management cancelled the ₹260 crore HPCL sale it earlier vowed to recover, while targeting 10-11 kbd by June 2027 and 32 kbd by 2029 via 20 wells and infrastructure builds.
Inconsistency HPCL dispute: In Feb 2026, management said HPCL's crude quality claim had 'no basis' and it was pursuing all avenues to recover ₹260 crore dues. In Jun 2026, it reversed the invoice, cancelled the sale, and resold the crude to third parties. Dirok pipeline: The DNPL line connection was expected by end-March 2026; now delayed by one to two months.HOEC's ambition is real; its credibility on execution has taken a hit with the HPCL pivot and pipeline delay.
-
Happy Square's margin story flips mid-call: IPO costs became AI spend
Management first told analysts EBITDA compression was due to one-time IPO expenses. Later in the same call, they said heavy AI investments were the real cause, raising questions about cost transparency.
Inconsistency Management first said EBITDA margin drop was due to one-time IPO expenses. When pressed, they pivoted to say heavy AI and technology investments were the primary driver, without reconciling the two explanations.Happy Square's 80% growth promise is real; the margin story changed mid-call. FY28 will be the credibility test.
-
Arabian Petroleum's debt strategy contradicts itself in same call
CEO cites term loan for ₹5 cr capacity expansion, but later tells analysts the focus is on reducing long-term debt. Meanwhile, operating margins fell from 6% to 4%.
Inconsistency Within the same call, management first stated it is using a new term loan to fund a ₹5 crore capacity expansion. Later, when an analyst questioned rising debt, they claimed the focus is on reducing long-term debt and limiting debt to short-term working capital. No explanation was given for the contradiction.A solid growth story with a margin and credibility problem. Fix the debt messaging first.
-
RMC Switch slashes Pulse Box TAM by 65%, extends order book timeline
Addressable market cut from ₹1,40,000 cr to ₹50,000 cr; order book execution pushed from 12 months to 2 years — both contradictions from prior call.
Inconsistency Pulse Box addressable market reduced from ₹1,40,000 crore (Nov 2025) to ₹50,000 crore (Jun 2026). Order book execution timeline extended from 12 months to 2 years for electrical EPC.RMC's growth trajectory looks impressive, but the timeline and addressable market reductions raise hard questions about execution reliability.
-
IFB's AC motor progress has reversed from February claims, and the capex target was missed
Three management statements from prior calls didn't hold up. The biggest credibility gap is in the engineering division's external sales push.
Inconsistency In Feb 2026, management said AC motor supplies to Voltas and Blue Star had 'already started to go up.' In June 2026 they said the motor is still in trials and all sales are internal. In Feb they said ₹100 cr engineering capex was 'nearly' done; in June they admitted only ₹63 cr was deployed by March.IFB's washing machine business is solid, but the company's credibility on engineering and product timelines is damaged.
-
Sealmatic's 2% revenue growth misses its own 15-20% target by a mile
EBITDA margin fell 700 bps to 17% after management assured investors it would hold at 20%, as the company invested in a long-term aftermarket strategy.
Inconsistency In June 2025, CEO Umar Balwa guided for 15-20% annual revenue growth 'for the current financial year and for the years to come.' By June 2026, growth was 2%. Separately, in November 2025, Balwa told investors EBITDA margins would be 'similar' to the first half's 20%. The full-year figure was 17%, a 700 bps miss.Sealmatic's long-game aftermarket strategy is sound. Its guidance track record is not.
-
GP Eco's order book claims contradicted itself within the same investor call
Management announced a ₹300 cr BESS order book in prepared remarks, then told analysts the orders were still being finalised minutes later
Inconsistency In the prepared remarks of the June 2026 call, GP Eco's management stated it closed the year with a 'confirmed' BESS order book of ₹300 cr. When an analyst asked for the confirmed order book in the Q&A, management contradicted itself, saying orders were still in final stages of discussion and deferring exact figures to September 30.The BESS market is real; GP Eco's ability to narrate its own pipeline in a straight line is not.
-
HRH Next said AI won't cut jobs. Then it said margins improved from cutting jobs.
The contact center outsourcer contradicted itself on headcount in the same earnings call, then capped margin guidance at 15% after hinting at more.
Inconsistency In prepared remarks, MD Ankit Shah stated AI integration would not lead to job reductions. Minutes later, in Q&A, he attributed EBITDA growth directly to manpower consolidation under 'Operation Green Cover' — contradicting his own statement. On margins, management first guided for expansion beyond the typical 10-12% PAT range, then within the same call capped it at a maximum of 15%.The numbers are moving in the right direction. The commentary needs to stop contradicting itself.
-
Fredun Pharma's mobility guidance doubled in three months. Management didn't explain why.
The pet platform launch slipped five months, the physiotherapy brand launch slipped three, and growth projections jumped from 25-30% to 55-60% CAGR without a bridge.
Inconsistency In February 2026, management guided for mobility segment growth of 25-30% YoY. In June 2026, it claimed a 55-60% CAGR, a near-doubling of the projected rate with no stated driver. Separately, the Mobilitix brand launch slipped from an April 2026 commitment to July 2026.Fredun's pivot is real, but the guidance now moves faster than the business it describes.
-
Addictive Learn scrapped its 300-person sales plan and killed its US university bid
CEO Ramanuj Mukherjee admitted to 18 months of missed guidance, shelved international expansion, and is now betting on AI to replace a human sales team he once promised to triple.
Inconsistency In May 2024, Addictive Learn planned to scale its sales force from 80 to 300 people. In June 2026, it said the team was cut to 40-50 closers, replaced by AI. In December 2024, management said it had narrowed down two US/UK universities to acquire. In June 2026, it said it pulled back from the US entry and put all international expansion on hold. Revenue guidance of ₹120 cr for FY26 missed by a wide margin; actual revenue was ₹75.7 cr.Addictive Learn is trading its credibility for optionality — a bet that only works if the AI sales engine scales.
-
Paramount's MD blamed depreciation for the EBITDA miss. Then he was told it doesn't affect EBITDA.
Managing Director Ali Asgar Roshan Hararwala cited depreciation to explain a margin shortfall, then conceded the error when an analyst pointed out the mistake. The real issue is market volatility.
Inconsistency In the same call, MD Ali Asgar Roshan Hararwala initially attributed the inability to achieve 14-15% EBITDA margin in FY27 to higher depreciation from newly capitalized assets. When an analyst noted depreciation does not impact EBITDA, he reversed his explanation, conceding the error and citing market volatility and rising manufacturing costs instead.Paramount's capacity expansion story is intact, but the MD's EBITDA stumble makes the margin guidance harder to trust.
-
Trident Techlabs scrapped its semiconductor M&A plan and walked back three years of guidance
After two years of telling investors it was in advanced or final stages of an acquisition, management suddenly pivoted to an organic build and dropped its ₹1,000 cr revenue target entirely.
Inconsistency For two consecutive calls, management told investors it was in advanced or final stages of acquiring a semiconductor company to accelerate growth. In June 2026 it abruptly abandoned that strategy, citing due diligence concerns, and said it would build the team organically instead. It offered no prior signal of the reversal.Trident Techlabs' new 30% CAGR target is only credible if it stops changing the rules.
-
Aegis Logistics has a ₹5,000 cr capex plan. Its Kochi project just went backwards.
LPG distribution margins hit ₹7,000/MT and Q4 was a record quarter. But management downgraded the Kochi expansion from 'underway' to 'evaluating' with no explanation.
Inconsistency In January 2026, CMD Raj Chandaria said the 60,000 cubic meter liquid expansion at Kochi port was 'now underway'. In June 2026, management said the same project was 'under evaluation'. No reason was given for the step back from construction to planning.Aegis is printing cash from LPG, but the Kochi backslide means not every project in the pipeline deserves equal trust.
-
Dev IT's EBITDA guidance miss was predictable. The explanation is the problem.
Management cited low-margin India focus as the reason for a 69% profit drop, the same factor it used last quarter to predict stability.
Inconsistency In the Nov 2025 call, management guided to a similar EBITDA as the prior year, acknowledging the low-margin India focus. In the Jun 2026 call, after EBITDA crashed to ₹7.23 cr from ₹23.7 cr, management cited that same India focus as the primary reason for the collapse.Dev IT is growing, but its guidance has become a story it tells itself between quarters.
-
Aegis Vopak's South India capacity plan hit pause, despite earlier 'definite' 2026 deadline
Mangalore and Kochi expansions were confirmed 'underway' in January. Now timelines are off the table.
Inconsistency In the Nov 2025 call, CEO Raj Chandaria guaranteed the 60,000 cubic meter capacity expansions at Mangalore and Kochi would be done by December 2026. In Jan 2026, he said Kochi was 'actually underway'. In the Jun 2026 call, he said timelines would only be provided 'once plans are fully finalized', walking back both the deadline and the construction status without explanation.Aegis Vopak's growth story is intact, but its South India silence leaves a hole in the capex narrative.
-
VMS TMT's solar savings estimate halved itself during the same earnings call.
Management first said ₹5 cr annual savings from its 15 MW captive solar plant. Minutes later, it said ₹5-6 cr in half a year.
Inconsistency On the same call, VMS TMT first stated the 15 MW captive solar project would save 'approximately ₹5 crores on an annual basis'. It later said 'we expect a 5 to 6 crore saving in the power bill on a half-yearly basis'. The same number was given two different timeframes without explanation.VMS TMT's solar plant is a fine project, but management can't seem to agree on what it saves.
-
VL Infra gave two different order book numbers in the same earnings call.
The infrastructure contractor said its order book was ₹280 cr in its opening remarks. Twenty minutes later, in Q&A, the number was ₹218 cr.
Inconsistency In the prepared remarks of the same call, management stated the company closed FY26 with an order book of approximately ₹280 cr. During the Q&A session, management explicitly stated the outstanding order book balance was ₹218 cr. The variance of over 20% was not explained.Two order-book numbers, one delivery promise that doesn't hold. The business may be fine, but the call didn't inspire confidence.
-
Ganesh Benzoplast's lease costs jumped 25% above its own guidance
JNPT plot rentals are now ₹25 cr a year, not the ₹18-20 cr management estimated six months ago. The margin math has shifted on both the lease and the expansion.
Inconsistency In November 2025, management estimated revised JNPT lease rentals would total ₹18-20 cr per year. In June 2026, the finalized number was ₹25 cr, 25% above the top end of their prior guidance. Separately, management guided 90% EBITDA margins on new expansion capacity in November; that figure was revised to 80%.Management guided 18-20, the number came in at 25. When guidance misses by 25%, the next round of numbers deserves extra scrutiny.
-
Simca gave two different numbers for SBI billing on the same call
The agency division's revenue share was also stated as both 10-15% and 15-20% in the same earnings call
Inconsistency Simca's management contradicted itself twice in a single call. On the SBI contract, they first said ₹15 cr was billed in the first two months of FY27, then later said ₹25 cr was billed. On the agency division's revenue share, they first forecasted a long-term maximum of 10-15%, then immediately stated it was already 15-20% and targeted to reach 30% by year-end.A digital conversion story deserves financial statements that agree with themselves.
-
Patel Retail cut its store expansion guidance by a third and stopped quoting its export order book.
Same-store growth fell from 8% to 5% without explanation. The inventory overhang is real, but the management consistency problem is bigger.
Inconsistency In Feb 2026, Patel Retail guided for 10-15 new stores per year to reach 65 by FY27. In Jun 2026, that was quietly cut to 8-10 with no explanation. Same-store sales dropped from 8% to 5%, which management dismissed as 'normal' despite citing the higher baseline four months ago. And in Nov 2025, CEO Patel gave a precise ₹50 crore export order book number. This quarter he said he 'cannot give a rough ballpark figure' for the same metric.Patel Retail cut its store guidance and stopped quoting its export order book. The numbers are fine; the explanations are missing.
-
VTM halved its own revenue growth guidance three months after setting it
Management told investors in January that top-line growth would be 25% for two to three years. This quarter, it guided 12-14% for FY27. The other guidance problems are just as stark.
Inconsistency In January 2026, VTM's management projected top-line compound annual growth of approximately 25% over the next two to three financial years. In June 2026, it guided only 12-14% for the current year, a direct halving. Inventory guidance also flipped: prior guidance was 1.5-2 months of sales; this quarter, inventory stood at 122 days (over 4 months).VTM's January guidance was aspirational. The June guidance is reality.
-
Hinduja Global recasts client losses as strategy. The prior call said they were involuntary.
Management now calls FY26 run-offs a disciplined portfolio rebalance that cut concentration risk. Six months ago, it blamed vendor diversification by clients.
Inconsistency In the Feb 2026 call, management attributed revenue softness to involuntary client actions: vendor diversification and in-house transitions. In the Jun 2026 call, it recast the same volumes as intentional, portfolio-rebalancing decisions that mitigated client concentration risk. The prior explanation was client-led; the current one is management-led.When a company rewrites the reason for its revenue shortfall, the new version needs more proof than the old one.
-
Blue Cloud shifted its data center timeline and cut its capex plan in a single quarter
The AI services firm advanced its first data center launch by a year while slashing the initial capital commitment from $350m to ₹150-200 cr, without explaining the pivot
Inconsistency In March 2026, management confirmed a 100-megawatt Phase 1 data center rollout with $350m in capex, targeting FY 2028. In June 2026, it advanced the timeline to Q1 2027 and cut the initial capex to ₹150-200 cr, leaving the earlier plan unexplained.The data center timeline moved forward, but the budget and ambition moved back.
-
Knowledge Marine made four guidance reversals in four months. The tax math changed the most.
Feb 2026 called the tax bill under 1% of turnover. Jun 2026 said 20% of revenue faces standard corporate tax. Three other reversals followed.
Inconsistency Four reversals since February: (1) Tax guidance — Feb 2026 said total tax would be <1% of turnover; Jun 2026 clarified that 20% of revenue (shipbuilding) faces standard corporate tax, with only 80% (chartering/dredging) under tonnage tax. (2) Capital deployment — Feb 2026 said ₹285 cr preferential would deploy over 3 years; Jun 2026 shortened that to 12–16 months. (3) Bahrain project — Feb 2026 denied it was on hold; Jun 2026 paused it indefinitely. (4) Quarterly benchmarks — Feb 2026 called Q3 results the new norm; Jun 2026 walked back to yearly guidance only.Four reversals in four months is not a trend yet, but it is a pattern. The tax math change demands an explanation management has not given.
-
Rishi Laser shelved its tube business. It was supposed to be a growth vertical.
The company now cites bandwidth issues. Twice before, management called it a promising expansion.
Inconsistency In the May and November 2025 calls, management described the tube processing segment as a promising, high-growth expansion opportunity. In June 2026, they said it has been shelved for at least 12 months due to bandwidth issues during the Malur plant shift.Rishi Laser's Malur plant is live, but proving the ramp after two abandoned strategies is the next test.
-
Tembo's defense guidance contains a mathematical contradiction
The company targets 30-35% EBITDA margins on ₹300-400 cr revenue while guiding ₹170-180 cr PAT. The numbers don't add up.
Inconsistency In the same June 2026 call, Tembo's management set two conflicting financial targets for its new defense segment. It guided for a 30-35% EBITDA margin, but separately guided for ₹170-180 cr PAT on ₹300-400 cr revenue — implying a 42-60% net margin, which is mathematically impossible if EBITDA is only 30-35% of revenue.When your new growth segment's guidance can't survive a calculator, the rest of the deck deserves extra scrutiny.
-
Delta Autocorp contradicted itself on a ₹20 crore government order in a single earnings call
MD Ankit Agarwal first said only ₹8-10 crore of a delayed order would mature. Minutes later he said the full ₹20 crore is locked in for FY27.
Inconsistency Early in the Q&A, MD Ankit Agarwal said Delta was optimistic only about the remaining ₹8-10 crore of a delayed ₹20 crore government order. Pressed later, he contradicted himself: 'we definitely expect that the entire ₹20 crores should be executed in FY27.' The same call. Two different numbers.Delta's three-year plan needs a ₹20 cr order its CEO can't describe consistently in a single earnings call.
-
Nis halved its FY27 revenue guidance, but didn't explain why.
The security services company cut its growth outlook to 12-15% from 20% just six months ago, raising a credibility question on its order-book claims.
Inconsistency In November 2025, Nis's CEO forecasted approximately 20% revenue growth for FY27, citing newly acquired contracts. In June 2026, the CFO lowered the guidance to 12-15% without explaining the reduction. The company did not address the gap between the two projections.Nis's guidance cut is bigger than the quarter itself. The explanation is still missing.
-
DentalKart disowns its own revenue guidance and brand-mix target
CEO Vikas Agarwal retracted the INR 500-600 cr FY27 target and the 70% own-brand share goal, calling both products of past immaturity.
Inconsistency In Nov 2023, management projected INR 500-600 cr annual revenue within three years. In June 2026, it retracted the target, citing immaturity in handling capital markets. The 70% own-brand sales mix goal from 2023 was also abandoned; management now caps it at 45-50% to protect platform neutrality. A sub-three-day delivery target was missed, with Tier 3-4 delivery still at five days.DentalKart is now selling honesty where it once sold a 3-year plan. The open question is whether that's enough.
-
Ashapura's Guinea port expansion is delayed by 18 months. Iron ore commercialization is too.
Both infrastructure projects cited as on track in November 2025 have been pushed back without a clear explanation for the shift.
Inconsistency In Nov 2025, management stated that both the BOFFA and GSM port expansions were on track to complete by Q2 FY27. In Jun 2026, the GSM port timeline was pushed to the end of FY28 — an 18-month delay. Separately, the iron ore commercialization, expected within two quarters of the prior call, is now described as 'slower than expected' with contribution deferred to 'the coming year or two.'Ashapura's FY26 numbers were real. The port and iron ore delays suggest the FY27 targets are aspirational.
-
Aztec Fluids walked back three commitments in one year: debt, imports, and margins
Management told investors in May 2025 it needed no debt, relied less on imports, and would expand margins. This quarter it said the opposite on all three.
Inconsistency In May 2025 Aztec said it foresaw no debt and negligible interest costs. In June 2026, debt was named as the second of three funding sources for expansion. The same reversal happened on import reliance (claimed to be declining drastically in May 2025; admitted to be still dependent in June 2026) and EBITDA targets (projected expansion to 23-25% in May 2025; revised to maintaining 13-14% in June 2026).Aztec's numbers hold, but management's guidance now carries a credibility discount that didn't exist a year ago.
-
Khazanchi cut its flagship store's revenue target by ₹100 cr without explanation
Profit doubled in FY26 on a shift to higher-margin designer jewelry, but management's flagship guidance has dropped and its own timeline has slipped.
Inconsistency In February 2026, management said the Chennai flagship was inaugurated on February 7 and cited ₹20 cr in first-10-day sales. In June, it said the store had only been open two months, implying an April opening, and cut the annual revenue target to ₹450-500 cr from ₹550-600 cr. No explanation was offered for either the timeline shift or the guidance cut.Khazanchi's numbers are improving, but the flagship store's story keeps changing.
-
Triveni's management missed both the sugar crush and the power transmission Q4 outlook
November 2025 guidance for higher sugar production and a 'fantastic' Q4 in power transmission gave way to an 8.8% crush decline and order deferrals.
Inconsistency In Nov 2025, management guided for a 'significant increase' in sugarcane crush and 'a very handsome amount' in sugar production. In Jun 2026, they reported an 8.8% decline, blaming jaggery diversion they called a surprise. Separately, they predicted an 'absolutely fantastic' Q4 for power transmission in Nov; Q4 was actually hampered by delayed orders and geopolitical issues.Triveni's operations are fine. Its guidance needs a credibility discount after two misses in seven months.
-
Ice Make's EBITDA margin landed at 6.9% in FY26. Management had guided 8% as a floor.
FY27 guidance is now 8-8.5%, cut from the 9.5-10.5% range management once called 'normal' after new capex.
Inconsistency In Nov 2025, management said FY26 EBITDA margin would be at least 8%. It was 6.9%. Separately, in Nov 2024, management said post-capex margins would normalize to 9.5-10.5%. Now it guides to 8-8.5% for FY27.Ice Make is growing fast, but its margin promises have a habit of shrinking.
-
Freshara's Spanish unit math doesn't add up on price or seasonality
Management claimed Q4 is 65% of sales, then gave numbers showing under 40%. The Sarrasa revenue target also contradicts its own pricing logic.
Inconsistency Management claimed 65% of FY26 sales occurred in Q4, but the same call said December-March sales were about ₹140 cr, less than 40% of ₹353 cr total income. Separately, the ₹500 cr revenue target for the Sarrasa facility implies a realization of over ₹1,300 per kilo, which contradicts the stated rule that olives sell for only three times the gherkin price of ₹61 per kilo.Freshara's platform pivot is real, but the numbers management used to explain it don't hold together.
-
JD Cables guided 15-16% EBITDA margin in November. Now it says 13%.
A new facility location that changed states, a conductor line six months late, and margins that fell after EPC entry — the company’s Nov 2025 guidance is largely unrecognizable.
Inconsistency In November 2025, JD Cables guided for 15-16% EBITDA margins and said its new conductor division would start by January 2026. In June 2026, it guided for ~13% margins and said the division was still waiting for an electricity connection. It also contradicted the location of its new facility across two states.JD Cables' numbers are growing. Its guidance track record from six months ago is not.
-
DC Infotech halved its services revenue target and walked away from margin guidance
A 2025 target to double the services mix within three years is now a more modest 25%. EBITDA guidance is gone entirely.
Inconsistency In May 2025, management set a target to double services revenue from ~19% within two to three years. In June 2026, it quietly reduced the aspiration to 25% with no explanation. Separately, a May 2023 goal of 'nearly double-digit' EBITDA margins by FY26 was abandoned at the FY26 results call, with management refusing to provide a new number.DC Infotech is asking for patience on a three-year AI story while cutting the targets that would prove it is working.
-
Neetu Yoshi broke its no-external-funds pledge within seven months
The company raised ₹29 cr via warrants for track working capital, contradicting a November 2025 commitment to fund all expansion through internal accruals until wagon manufacturing begins.
Inconsistency In November 2025, management stated all expansion capacities for the next three years would be funded through internal accruals, with no external fundraising planned until wagon manufacturing. In June 2026, they announced a ₹29 crore warrant issuance for track segment working capital. The prior commitment has been quietly abandoned.The internal-accruals pledge lasted one quarter. The bogie plant is running three months late, and bogie prices are down 17%. The ₹29 crore warrant is the first signal that growth will cost more than management first said.
-
QMS Medi cut its service margin guidance in half. It once said margins were 50%+.
Medical-camp operator told investors its core growth engine earns 25% EBITDA, not the 50%+ it cited in 2023. Camp cost structure also changed.
Inconsistency In August 2023, QMS Medi told analysts its camp and education business margins were 'very high... almost around 50% plus'. In June 2026, management said the entire service segment margin is around 25% — a 50% cut in the core growth engine's profitability. Separately, management previously said camp costs were fixed regardless of patient turnout; this quarter it acknowledged some camps operate on a variable per-patient model.The business is scaling, but the margin investors were sold in 2023 is gone.
-
Everest Kanto's Egypt plant is five months late and its US order book just shrank.
A 210 basis point jump in EBITDA margin masks two unexplained delays to key international expansion projects, stretching the revenue realization timeline.
Inconsistency In November 2025, Everest Kanto guided that the new Egypt plant would begin operations by January 2026. In June 2026, that target shifted to the end of June 2026, an unexplained five-month delay. The US order book execution timeline stretched from 12-18 months to 18-24 months, with the book itself declining from $80 million to $75 million.The domestic margin story is real, but the unexplained delays to international projects are a credibility check on management's execution.
-
Tenneco's exports fell to 5-6% of sales. Six months ago, management said 7-8%.
Record EBITDA margin of 18.8% and a DaVinci technology push anchor the FY26 results, but an unexplained drop in export contribution clouds the growth narrative.
Inconsistency In the Dec 2025 call, management stated export sales were 7-8% of value-added revenue. In the Jun 2026 call, they described current exports as 5-6% of sales with no explanation for the decline.DaVinci's technology story is real, but Tenneco must explain why the export foundation shifted beneath it.
-
Rathi Steel's melting shop fell to 50% after management targeted 85%
Record FY26 revenue growth masks a puzzling operational reversal in the steel melting shop, where utilization dropped from 65% to 50% with no clear explanation.
Inconsistency In February 2026, Rathi Steel management reported melting shop utilization at 60-65% and targeted 80-85%. In June 2026, they disclosed it had fallen to 50-52%, a 15-point drop from the range they had already achieved, without explaining the reversal.Rathi Steel's growth is real, but its melting shop backslide needs an explanation before the cost savings thesis holds up.
-
Affordable Robotic missed revenue guidance and diluted its Humro stake below 50%.
Standalone revenue fell 31% to ₹110 cr against a ₹160 cr commitment made in February. A ₹48 cr investment will cut its majority control of the growth subsidiary.
Inconsistency In February 2026, CFO Murthy told investors standalone revenue would match the prior year's ₹160 cr. It came in at ₹110 cr, a 31% miss. Separately, management said its 83% Humro stake would increase with funding. A pending ₹48 cr investment will cut it below 50%, stripping majority control.Two guidance misses and a subsidiary control flip in one quarter make the next set of numbers hard to trust.
-
Recode said 70% of online revenue came from its website. Hours later, it said 50%.
The same call also flipped on quick commerce: launched in two months, then not yet.
Inconsistency On the same call, management first claimed over 70% of online revenue came from its own website, then said 50% during Q&A. It also announced a quick commerce launch within one to two months, then reversed to say it was not doing quick commerce yet.A young company with strong growth must deliver consistent numbers to be taken seriously.
-
Anlon's capex quadrupled and CDMO timelines slipped. The explanations don't match.
Management said in November 2025 it had ₹31 cr saved for expansion and no need for debt. Now it's a ₹130 cr project with a ₹65-70 cr loan and delayed commercialization.
Inconsistency In November 2025, management stated the greenfield expansion would cost ₹31 cr, be fully funded by IPO proceeds, and require no debt. In June 2026, the capex estimate quadrupled to ₹130 cr and management announced a ₹65-70 cr bank loan. Separately, management said in November 2025 that CDMO validation was 'already completed' for three molecules with commercialization by Q3 FY27. Now, two of the three are only expected to complete validation by Q2 FY27, pushing commercialization to Q4 FY27 or Q1 FY28.The numbers are growing, but management's past words aren't matching its present ones.
-
Meta Infotech reversed three prior-quarter promises in one call
Imperva recovery, low-margin product defence, and 5x profit ambition — all quietly undone.
Inconsistency Meta Infotech's management contradicted itself on three fronts. In Nov 2025, it said Imperva disruption was resolved and revenue would recover in H2; in June 2026 it blamed the same acquisition for the miss. It defended low-margin product sales in Nov 2025; now it rejects anything below 5% margin. It guided to 5x PAT growth; now it's 4x.Meta Infotech's strategy pivot may be needed, but three reversals in six months ask the obvious question: what does this management actually believe?
-
Rushil Decor withdrew its FY27 revenue guidance after giving it twice before.
Management also cut its laminate margin target to 10-12% from 12-14% as chemical costs surged 40% and MDF oversupply looms.
Inconsistency In both the Nov 2025 and Jan 2026 calls, management guided for FY27 revenue above ₹1,000 cr. In the Jun 2026 call, they withdrew that figure entirely, offering no numerical revenue guidance. Separately, the laminate margin target was cut from 12-14% to 10-12%, with management now calling Jumbo margins 'quite varied' instead of the previously confident 14-16% range.Rushil Decor gave guidance, then took it back. The next test is whether the number returns.
-
All E Technologies halves its revenue target. The CEO says they didn't see it coming.
The Microsoft partner walked back its ₹1,000 cr goal and delayed its growth timeline after macro shocks. It's now promising $1 million in orders this month.
Inconsistency In February 2026, CEO Ajay Mian reaffirmed the ₹1,000 crore long-term revenue target. In June 2026, management replaced it with a ₹500 crore mid-term target over 4-5 years, saying they did not foresee the last 15 months. Separately, a November 2025 promise of growth returning in two quarters was missed; revenue declined ~1% in FY26.All E Technologies' target cut is an honest reset, but honesty only buys you one more call to prove the numbers.
-
Sunrakshakk's Guwahati plant ran at half capacity. Management had guided 85%.
The FMCG contract manufacturer missed its Q4 capacity ramp target by a wide margin, yet still claims a ₹1,000 cr FY28 revenue goal.
Inconsistency In February 2026, management projected overall FMCG capacity utilization would ramp to over 85% by end of Q4 FY26. In June 2026, it reported the new Guwahati facility, which houses the major expansion for soaps and cosmetics, was running at just 45-55%. No explanation was given for the shortfall.Sunrakshakk's top line is growing, but the Guwahati miss undermines the forecasts the ₹1,000 cr target depends on.
-
Thomas Scott's receivable days don't add up across three calls
Q4 revenue grew 63% to ₹78 cr, but management's own numbers on receivables and SKU count have shifted meaningfully since November.
Inconsistency In November 2025 and February 2026, management guided for long-term receivable days of 60-75 and 60 days respectively. In the June 2026 call, CEO Vedant Bang said receivables had fallen from 25 to 21 days, with no explanation for the discrepancy. Separately, SKU count swung from 22,000+ in February to 15,000+ in June, and brand count fluctuated between 12, 15, and 14 across the three calls.Thomas Scott is a fast-growing business. Its own numbers make it hard to verify.
-
Unihealth pushed its 1,000-bed target out by two years and then said it always planned it that way.
Management delayed the landmark expansion from FY26 to CY28, but on the June call claimed the new timeline matched its 2023 guidance. Ugandan receivables have ballooned to 320 days.
Inconsistency In Nov 2023, management guided to 1,000 beds by end of FY25-26. In Jun 2026, it pushed the target to CY28 and claimed it had guided to the new timeline since 2023, rewriting the record. Separately, Ugandan receivable days jumped from 120-135 in May 2024 to 320 in Jun 2026, with management now framing 180-200 days as an improvement.Unihealth's operational execution is ahead of its credibility.
-
Frontier Springs halved its margin guidance. Management offered no operational reason for the cut.
FY27 EBITDA margin guided to 23-24%, down from the 27% near-equivalence management promised in November. Steel costs and legacy contracts are the cited headwinds, but the explanation is thin.
Inconsistency In November 2025, management guided FY27 margins to be within 1-2% of FY26 levels (around 27%). In June 2026, the guidance was cut to 23-24%. When an analyst asked about the discrepancy, management attributed it to conservatism without providing an operational justification.The railway story is intact, but the margin cut without a clear operational why is the kind of guidance slip that makes you question the next one.
-
Ceinsys restated U.S. subsidiary revenue from ₹23 cr to ₹7 cr without explanation
A ₹140 cr downward restatement sits alongside missed unbilled-revenue guidance and an abandoned M&A timeline.
Inconsistency In February 2026, Ceinsys told investors the U.S. subsidiary had earned ₹19 cr in nine months and would hit ₹23-25 cr for the full year. In June 2026, management said full-year FY26 turnover was only ₹7-8 cr. The ₹140 cr gap has not been explained.Ceinsys is executing well, but the ₹140 cr subsidiary restatement is a credibility problem management hasn't answered.
-
Airflowa's revenue and receivable guidance contradicted itself in the same call
The company said in prepared remarks it would slow its ₹1,000 cr revenue timeline. Minutes later in Q&A it said it could arrive sooner. A receivables forecast flip-flop is just as stark.
Inconsistency Management gave two different ₹1,000 cr revenue timelines in the same call. In prepared remarks it said the timeline would "extend modestly" due to a profitability focus. In Q&A it said it could arrive "even sooner" than FY28. Separately, it guided that ~70% of ₹214 cr receivables would be collected by June-end, then said in Q&A only ₹100-110 cr (~50%) would come in and it would take 3-6 months to reach ₹150-160 cr.Airflowa's operational execution is on track, but the same-call guidance flip-flops on revenue and receivables demand a credibility discount.
-
Mishra Dhatu now says ₹2,000 cr revenue will take three years. In February, it said ten.
The defence materials maker also cut its near-term growth guidance to 12-15% from 20%, citing raw material and energy constraints.
Inconsistency In February 2026, Mishra Dhatu's management gave a ten-year timeline to become a ₹2,000 crore company. In June 2026, they claimed the timeline was always three years. Separately, a 20% revenue growth guidance was lowered to a 12-15% baseline without a clear explanation for the pivot.Mishra Dhatu's capabilities are advancing faster than its ability to guide on them.
-
Tega's Chile plant is delayed, its acquisition debt jumped 50%, and logistics problems are back
Management's logistics fixes from two prior calls didn't hold, the Chile plant pushed to late FY27, and parent debt rose to ₹1,500 cr from a stated ₹1,000 cr cap
Inconsistency Management said Middle East logistics issues were easing in the Nov 2025 and Feb 2026 calls. In June 2026, they blamed those same logistics disruptions for a significant revenue miss in consumables. Separately, management had confidently guided the Chile plant for Q2 FY27 commercial production in two prior calls; it's now pushed to late Q4 FY27 or FY28. Parent-level acquisition debt also rose 50% to ₹1,500 crore from a capped ₹1,000 crore.Three broken commitments in one call make the Mollycop integration story harder to trust without a detailed bridge
-
IFGL's Khurda timeline slips and Monocon breakeven delayed after customer loss
Management dropped its firm FY28 completion target for the ₹300-350 cr greenfield and pushed Monocon's breakeven to Q4 FY27, citing a lost UK customer it hadn't disclosed before.
Inconsistency Management committed to a Khurda greenfield completion by end-FY28 in both Nov 2025 and Feb 2026, calling it 'firmly on schedule.' In June 2026, it said the board is 'evaluating the pace and structure' of the investment. Separately, Monocon's breakeven was first guided for early FY27, then pushed to Q4 FY27 after the loss of a key high-margin customer due to a plant closure.IFGL's operational recovery is real, but two guidance walk-backs in one quarter make the next phase harder to trust.
-
Foods & Inns guaranteed Q4 EBITDA growth in February. It blamed a 'base effect' when Q4 missed.
CEO Moloy Saha's Q4 guarantee came months after the Kumbh Mela base he later cited as the reason for the miss.
Inconsistency In February 2026, CEO Moloy Saha guaranteed year-over-year EBITDA growth for Q4, calling it 'something that you can take for granted.' In June 2026, when discussing Q4 domestic volume declines, he attributed the miss to an unfavorable base effect from the prior year's UP Kumbh Mela — an event fully known to management when the guarantee was made.When a CEO guarantees a quarter and then blames a known event for the miss, the next guarantee needs more than words.
-
Dynacons said OEM deals locked in margins. Q4 margin fell 290 basis points.
CEO Parag Dalal blamed AI-ready component cost escalations for the sequential drop, four months after assuring investors no material cost pressure existed.
Inconsistency In February 2026, CEO Parag Dalal said Dynacons faced 'no material pressures' on margins because OEM pricing was locked in. In June 2026, he blamed a 290-basis-point sequential margin drop on 'technology component cost escalations and supply chain tightness' for AI-ready infrastructure. The earlier assurance does not match the later result.Dynacons's Q4 margin miss is less about a blip and more about a broken promise on cost protection.
-
Hi-Green Carbon confused its own plant map on the same earnings call
Management reversed the locations and roles of its second and third plants, while a six-month electricity generation delay went unexplained.
Inconsistency In June 2025 and November 2025, Hi-Green's management said Dhule was its second plant for electricity generation and Dhar was its third plant for syngas bottling R&D. In the June 2026 call, the Managing Director said the bottling would happen at the 'third plant at Dhule', reversing the map. The shift was not explained.Hi-Green Carbon is growing fast, but on this call it forgot which plant does what.
-
Signoria's export and capex guidance contradicted itself within the same call
Management set a 25% export target for FY27, then said they cannot give any numbers because exports haven't started. The capex story wobbled too.
Inconsistency In the same Q&A, management first stated a 25% export target for FY27. Minutes later, when asked for multi-year projections, they said they could not provide any exact numbers because the company has not started exporting. Separately, they initially said 200 new machines must be installed this year to meet demand, but later said the current setup can comfortably hit the ₹80 cr target and new machines are only planned for year-end to support FY28 growth.Signoria has real sales momentum but gave two different versions of its own plan in a single call.
-
Natural Capsules needs ₹25-30 cr more capex for API. Last year it said it was fully capitalized.
The PE clawback year shifted from FY27 to FY29. Management's API story keeps changing, and the turnaround math is getting harder.
Inconsistency In June 2025, management said the PE investor's clawback clause targeted FY27. In June 2026, it said the target is FY29. Separately, management previously said API facility capacity was fully capitalized for ₹240-300 cr revenue, but now says ₹25-30 cr more capex is needed for balancing clean rooms.Natural Capsules' turnaround requires more money and more time than management previously said. The explanations keep changing.
-
Indo Borax's CEO contradicts his own CFO on raw material costs in the same earnings call.
The company is guiding for ₹250 cr in revenue, but the call was marred by three internal contradictions, including a mathematical error on DOT capacity guidance.
Inconsistency The CFO directly attributed margin pressure to higher raw material prices from geopolitical conditions. Minutes later, the MD contradicted him, insisting raw material volatility for their sector is much lower than for other chemicals. Management also contradicted itself on whether a guided 25-30% revenue growth would come from volume or price, and made a mathematical error in quantifying DOT capacity utilization.The numbers are fine, but the explanations for them keep changing.
-
Exato cuts its growth guidance in half and chases hardware deals it once dismissed
ARR hit ₹120 crore, revenue grew 35%, and the order book is ₹600 crore. But the management reversed two prior positions in one call.
Inconsistency Exato's management made two sharp reversals. In February it called hardware transactions 'box selling' it didn't want to focus on. In June it announced a strategic push into AI infrastructure hardware, targeting 30-35% of revenue. Separately, the minimum CAGR guidance dropped from 'at least 30-40%' to 'at least 20% plus'.Exato is growing fast, but the strategy is moving faster than its explanations for it.
-
Pakka has reversed course on Guatemala, Ayodhya, and its entire project funding stack in six months
Guatemala and US operations paused, Ayodhya equipment to be removed, Jagriti delayed again, and the original lenders replaced by Neo Group debentures.
Inconsistency In August 2025, Pakka committed to a $15m Guatemala facility launching by June 2026. This quarter it's paused. It also reversed its Ayodhya strategy: having planned to rebuild and restart troubled machines, it now plans to remove or lease them out. And the entire Jagriti project funding was overhauled after a warrant subscription failure forced a replacement of the original lenders.Pakka's project portfolio has been reset. The next test is whether it can execute.
-
Kranti's turnaround is real. Three of its own targets aren't.
Revenue hit ₹100 cr and profit turned positive. But management quietly cut guidance on Jaipur, defense, and Pune utilization without explanation.
Inconsistency Management cut Jaipur Plant 4 FY27 revenue guidance by ~40% (from ₹20-22 cr to ₹12-14 cr), delayed defense segment scaling from a concrete FY27 target to a 4-6 quarter timeline, and left Pune facility utilization stuck at 65% after projecting 75-78%. None of the shortfalls were explained.Kranti's turnaround is real, but three cut targets with zero explanations is a credibility tax on the good news.
-
Fratelli missed its own revenue guidance twice. Now it's guiding 30% growth.
FY26 revenue grew just 1% against two prior guidance cuts. The company is now betting on an RTD doubling and cost discipline to hit FY27 targets.
Inconsistency Management guided 12-15% revenue growth in November 2025, cut it to 7% in February 2026 blaming first-half regulatory issues. In June 2026, FY26 growth came in at 1%, and management again cited the same first-half regulatory disruptions as the reason, without explaining why the revised Q4-dependent guidance also failed.Fratelli is betting the company on an RTD doubling to fix a track record of broken guidance.
-
Som Distilleries missed FY26 revenue by ₹267 cr after Bhopal shutdown dragged on for months
In February management called the license suspension immaterial and predicted a fix in days. Revenue fell 15% instead, and the plant is still closed.
Inconsistency In February 2026 management called the Bhopal license suspension an immaterial hurdle, said court resolution would come in '2 to 3 days', and held FY26 revenue guidance at ₹1,500 cr. In June it admitted the plant stayed closed for months, revenue fell to ₹1,233 cr, and it could not give a 'definite timeframe' for restart. Management also dropped its February commitment to increase promoter stake via open-market purchases, now tying any infusion to a specific capital need.Som Distilleries has given the same Bhopal restart timeline three times. Credibility is now part of the valuation.
-
Megatherm gave two capex numbers for this year. The CFO didn't explain the gap.
The induction furnace maker guided ₹20 cr for a new transformer shed early in the call, then agreed with an analyst that capex would be ₹5-10 cr for two years. The discrepancy matters for near-term cash flow.
Inconsistency Early in the June 2026 call, CFO Satadru Chanda said the new transformer shed would cost 'around 20 crores' in capex this year. Later in the same call, he agreed with an analyst's projection that capex would be '5-10 crores' for the next two years. The two statements cannot both be correct for the same timeframe.The transformer story is real. The capex number on the same call was not.
-
BR Goyal missed its order book target by 38% and cut its FY27 margin guidance
The ₹2,000 cr FY26 order book target came in at ₹1,235 cr. FY27 EBITDA margin target dropped to 10-11% from 13-14%.
Inconsistency In November 2025, management guided for a ₹2,000 cr order book by March 2026. The actual figure was ₹1,235 cr, a 38% miss with no explanation. On the same call, they guided FY27 EBITDA margin to 13-14% and now say 10-11%, citing sector structure and project mix.The operational execution is real, but the guidance credibility needs rebuilding after a double miss.
-
Izmo missed its FY26 breakeven target for Izmo Micro. The CEO didn't explain why.
The division stayed in the red despite two prior years of explicit guidance, as the company shifts focus to a multi-year photonics ramp.
Inconsistency Management guided for Izmo Micro operational breakeven in both June 2025 and November 2025. In the June 2026 call, they acknowledged a sustained Q4 loss and an ongoing investment phase without addressing the missed target.Izmo's photonics opportunity is real. Its track record of hitting its own targets is not.
-
Supreme Power dropped its switchyard EPC strategy without explanation
The transformer maker guided for ₹275-300 cr revenue in FY27 after a capacity expansion, but the silent exit from a previously announced business line raises questions about strategic clarity.
Inconsistency In October 2024, CMD V. Rajmohan said a ₹26 cr order marked the company's entry into switchyard construction and commissioning, calling it a key expansion into high-voltage infrastructure. By June 2026, that business line was omitted entirely, with the company redefined as a dedicated transformer manufacturer. The pivot was not explained.The transformer boom is real, but a silently abandoned strategy makes the company's own story harder to trust.
-
Solarium says government receivables are inherent. Last quarter it said they were a one-off.
A deliberate shift to ground-mounted EPC and solar kits follows two reversals in management's own stated rationale within seven months.
Inconsistency In November 2025, management assured investors that receivable delays were a one-off issue with defense projects and that other distributed programs like NTPC had no issues. In June 2026, it blamed NTPC site challenges and called receivable delays inherent to government distributed programs. Separately, it pivoted from touting end-to-end installation as a moat to launching solar kits to de-scope that very work.Solarium's order book is real. Its strategy, explained twice differently in seven months, is not.
-
Chaman Lal Setia denied Iran business in February. It blamed an Iran shipment delay in June.
The basmati exporter's stockpile of low-cost rice is printing money, but two contradictions on the same call demand answers.
Inconsistency In the Feb 2026 call, management stated it had stopped doing business with Iran 'for years altogether'. In June 2026, it attributed a 9% quarterly export volume drop to shipments being stuck due to the situation in Iran. Separately, new manufacturing units described as 'fully working' in February were said to be at 'around 50% efficiency' in June.The rice inventory trade worked, but the contradictions in the same call make management's commentary hard to trust.
-
Jeena Sikho's Entero pharmacy tie-up is dead. Management didn't explain why.
Two calls after promising 1 lakh pharmacy doors via Entero, the deal collapsed over costs. The bed expansion is also months behind schedule.
Inconsistency In November 2025 and February 2026, management said an exclusive Entero distribution deal would put products in 1 lakh pharmacies imminently. By June 2026 the deal is off. CEO Manish Grover cited Entero's demand that the company bear additional expenses. No alternative retail distribution plan was disclosed.The financials are strong, but the strategy updates keep going stale.
-
Suba Hotels has a 1,759-key pipeline. Its own executives disagree on how half of them will be built.
The CEO wants revenue-share to control the guest experience. The VP of BD says 500 keys in FY27 will be franchises. No explanation was given for the split.
Inconsistency Within the same June 2026 call, CEO Mubeen Mehta said Suba's preferred expansion model is revenue-share and leases to maintain operational control. The VP of Business Development then broke down the FY27 pipeline: 507 leased/owned keys and the remaining 500-odd keys as franchise — zero revenue-share keys. Management offered no explanation for the mismatch between the stated strategy and the pipeline allocation.Suba's 1,759-key pipeline is real, but the company can't tell you what half of it is.
-
Basilic Fly's receivables problem is two years old. Management's reassurance hasn't changed.
₹44-45 crore of old receivables remain uncollected despite repeated promises to clear them, while margin guidance has also slipped.
Inconsistency In November 2024, management assured investors aged receivables would be fully collected by early 2025. Almost two years later, ₹44-45 crore remains uncollected and the resolution timeline has been pushed again to H1 FY27, with the same reassurances. Separately, in November 2025 management projected H2 seasonality would lift margins; FY26 ended with PAT margin contracting 250bps.Basilic Fly's India business is working. Its receivables promise still isn't.
-
Tolins Tyres guided 20% EBITDA margin 18 months ago. Now it's 10-13%.
The same GST cut the company called transformative is now blamed for destroying retreading economics and compressing margins by half.
Inconsistency In Nov 2025, management hailed the GST reduction on new tyres as a 'transformative step' that would stimulate demand. By Jun 2026, it blamed those same tax changes for eroding retreading's price advantage and causing severe margin pressure. Separately, Nov 2024 guidance of ~20% structural EBITDA margins was quietly downgraded to 10-13%.Tolins called the GST cut transformative. It transformed the margins from 20% to 10-13%.
-
Sonam's margin guidance contradicted itself within the same call
Revenue grew 64% but PAT margin compressed to 4.3%. Management first promised year-on-year margin improvement, then said it might not grow in percentage terms.
Inconsistency Sonam's CEO first stated margins would 'certainly' grow year-on-year, then immediately clarified that percentage terms might not increase, only the absolute margin would. Both statements came in the same call, under the same line of questioning.Sonam's margin improvement story is really a volume story dressed in better language.
-
Titagarh missed its passenger coach target by 50%. Two quarters ago, it said it was on track.
The company delivered 63 coaches in FY26 against a 100-120 target, while also admitting its Italian subsidiary was a bigger cash drain than previously stated.
Inconsistency In the November 2025 call, management said it was 'well on track' for its 100-120 passenger coach FY26 target. In June 2026, it disclosed delivering only 63 coaches, a miss of nearly 50%, without a clear explanation for the late-year projection failure. Separately, in August 2025, management stated there was 'no cash loss or potential cash loss' from the Firema subsidiary. In June 2026, it directly contradicted that, citing 'continuous cash needs on account of the losses that it was incurring' as a reason for the exit.Titagarh's passenger rail transformation is real. Its management's ability to accurately forecast it is not.
-
Kellton cited war and AI for US deal delays after dismissing both risks months earlier
Management flagged geopolitical uncertainty and AI-driven customer hesitation as headwinds to project sign-offs — a reversal from its November and February reassurances.
Inconsistency In Nov 2025, CEO Niranjan Chintam said he did 'not believe anything is going to happen with the American market' despite talk. In Jun 2026, he attributed slower US growth to the war causing delays at the final contract stage. Separately, in Feb 2026 he called AI impact on enterprise demand a 'market overreaction'; by Jun 2026, AI-driven efficiency expectations were stalling signings.Kellton's management rewrote its risk playbook twice in eight months. The next 60 days decide which version holds.
-
Olectra was L3 on 700 buses it previously said it would win. It also reversed on supply chain.
The EV bus maker said in February it had no supply chain problems; this quarter it blamed production challenges on geopolitics. And a key tender status was overstated.
Inconsistency In Feb 2026, Olectra's management said they were free of supply chain issues and expected none in Q4. In Jun 2026, they blamed Q4 production challenges on "turbulent times due to war." Separately, they claimed in Feb to be L1 on a 1,785-vehicle CESL tender, but disclosed in Jun that they were L3 on 700 of those buses.The numbers are good. The story is less clean. Two reversals in six months are a small trust tax on an otherwise strong growth trajectory.
-
Rico Auto's railway revenue was ₹3-4 cr last year, not the ₹80-90 cr it guided
Management repeatedly claimed railway deliveries were underway. They weren't. Now it's a ₹100 cr FY25 target from a near-zero base.
Inconsistency In Nov 2025 and Feb 2026, Rico Auto management said it was actively delivering railway components and was on track for ₹80-90 cr and then ₹60-65 cr in railway revenue. In the June 2026 call, CFO Naveen Sorot admitted railway revenue was just ₹3-4 cr in FY24 because approvals were delayed, contradicting prior claims of established momentum. Management also guided to 12-13% EBITDA margins by Q4 FY24; actual Q4 EBITDA margin was 7.1%, with the target quietly reset to 'above 10.25%' for FY25.Rico Auto's railway and margin guidance was repeatedly stated and repeatedly wrong. The ₹100 cr FY25 railway target is now a credibility test.
-
Shalibhadra's 100-branch target slipped by two years in the same earnings call
Management stated FY27 for 100 branches early in the call and FY29 later. They also claimed full automation, then described a manual underwriting process.
Inconsistency In the opening remarks, management said Shalibhadra is targeting 100 branches by FY27. During Q&A, the same management said the 100-branch target is FY29, a two-year gap. Separately, management claimed nearly 100% automation in onboarding, underwriting, and collections, but later described their standard credit appraisal for rural customers as a highly manual process requiring physical receipts and verbal checks from village headmen.Shalibhadra's numbers are fine for now. Its call was not.
-
Gufic's margin recovery timeline has moved forward by two years
Indore break-even and a restructured critical care book have accelerated the path to 18% EBITDA in FY27, versus the FY29 timeline management gave investors last August.
Inconsistency In August 2025, management told investors EBITDA margins would not pick up until FY29 at the earliest. This quarter, management guided FY27 EBITDA to ~18%, a two-year acceleration that was not previously signposted. Separately, the Canadian dermal fillers launch, targeted for June-July 2026, has slipped to Q3-Q4 FY27 with no explanation for the delay.Gufic's margin recovery arrived a year ahead of schedule. Now it has to stick.
-
Xelpmoc's Mihup ARR dropped from ₹1 billion to $1 million. No explanation given.
Management also walked back a specific breakeven timeline after giving one last quarter, raising credibility questions on both portfolio reporting and forward guidance.
Inconsistency In November 2025, management stated Mihup's contracted ARR was ₹1 billion. In June 2026, it was reported as $1 million. Separately, management previously guided breakeven within '1, 2 quarters' but this quarter refused to provide any timeline.Two unexplained reversals in one quarter make management's future commentary harder to trust.
-
NBCC missed its FY25 revenue target and quietly moved the same goalpost to FY26
Management guided ₹14,000-15,000 crore for the fiscal year just ended. It hit ₹10,000 crore. The same target is now the FY26 goal.
Inconsistency In November 2025 and February 2026, NBCC management guided ₹14,000-15,000 crore standalone revenue for FY25. In June 2026, they reported surpassing only ₹10,000 crore and set the same ₹14,000-15,000 crore target for FY26 without acknowledging the miss. The Ghitorni project's profit recognition timeline was pushed from FY27-28 to FY29-30. Reported Amrapali Phase 1 completions were revised downward from 36,000 units to 33,000.When guidance is a moving target, the number matters less than the story behind the miss.
-
Sharat's cost containment claim lasted four months
Q4 fish meal inflation hit margins despite February guidance that inventory stocking had locked in optimal feed costs.
Inconsistency In February 2026, management told investors it had successfully mitigated fish meal price inflation through strategic stocking, asserting feed production costs were optimal. By June 2026, the company blamed the same input costs for compressing full-year profit margins.A good quarter on the topline. A bad one for the credibility of cost guidance.
-
Manoj Ceramic's manufacturing strategy reversed within six months, with no explanation.
PAT grew 10% on 23% revenue growth. Management celebrated manufacturing in November, then called it a high-capital risk in June.
Inconsistency In November 2025, management described MCPL's entry into manufacturing as a significant step towards value chain integration. By June 2026, the same team was calling its motto 'asset-light' and framing physical manufacturing as a high-capital risk that limits product agility.Manoj Ceramic's profitless growth is a problem, but its strategic incoherence is the bigger concern.
-
JM Financial reverses digital spend, real estate lending in single call
Three months after pledging investment in tech and real estate, management cut digital burn and paused property loans, citing poor risk-adjusted returns.
Inconsistency In February 2026, CEO Vishal said the real estate book had hit a trough and 'will only grow from here.' This quarter he reversed that, stating risk-adjusted returns are unattractive and the company is going slow. Separately, management committed to ongoing digital investment in February but is now cutting digital and BlinkTrade spend significantly over 3-6 months.Three reversals in one quarter suggests JM Financial is still searching for a strategy, not executing one.
-
Uflex said its cost of funds was 7% and falling. Now it's 9% and refinancing is off the table.
Q4 EBITDA hit a 14-quarter high, but the financing narrative just flipped. Blended cost of debt jumped 200 bps and management abandoned the refinancing plan it promised in February.
Inconsistency In February 2026, management said the blended cost of funds was stable around 6.9%-7% and would decline further due to planned refinancing. In June, the blended cost jumped to 9% and management dismissed refinancing as premature, without explaining the reversal.Uflex's EBITDA recovery is real, but the 200 bps jump in the cost of debt it didn't warn about will shadow the capex cycle.
-
Jupiter Wagons reversed its muted FY27 outlook within a quarter. No catalyst was named.
In February, Vivek Lohia said FY27 would remain muted. In June, he said numbers would be 'much better'. The supply-chain story hasn't changed.
Inconsistency In the Feb 2026 call, CEO Vivek Lohia set expectations for a muted FY27, citing ongoing supply constraints and advising that strong growth would not resume until FY28. In the Jun 2026 call, Lohia reversed this, guiding that FY27 numbers would be 'much better than the previous financial year' without identifying a specific catalyst that materially altered the timeline.When a CEO gets less cautious without a new fact, the market should too.
-
Emerald Finance's ₹9,500 cr NBFC book shrank to ₹111 cr. Management hasn't explained why.
Two prior claims of a massive SME loan book collapsed into a ₹111 cr reality. The EWA business also stalled against its own guidance.
Inconsistency In the Oct 2025 call, management claimed its own NBFC loan book sat at 'close to ₹9,500 crores'. By Jan 2026 it said AUM was 'roughly ₹103 crores'. This June it acknowledged the book is ₹111 crores. The 95x discrepancy in stated lending scale has not been explained.Emerald's revenue is growing, but the company needs to explain the ₹9,500 cr book that became ₹111 cr.
-
3B Blackbio's M&A focus and contract math keep shifting between quarters
Management expanded its acquisition horizon, revised down executed Coris volumes, and repackaged a missed growth target as a base-effect story — all without acknowledging the contradictions.
Inconsistency Three significant contradictions between the Feb 2026 and Jun 2026 calls. First, management said M&A was limited to molecular diagnostics in Feb; now it's expanding beyond IVD. Second, the Coris HAT contract executed amount dropped from ₹3.45 million to ₹2.6 million without explanation. Third, FY26's 10% domestic growth was initially projected at a minimum 15%, but was later attributed to a tough prior-year base that was originally cited as a tailwind.When the math and the narrative keep changing, the guidance is the least credible part of the story.
-
Ganesh Housing said it would stay debt-free. Then it borrowed ₹300 crore.
A debt-free commitment repeated in two prior calls was reversed this quarter with no apology and new guidance to expect more borrowing.
Inconsistency In the Nov 2025 and Feb 2026 calls, management repeatedly promised to remain debt-free through FY27. In the Jun 2026 call, it revealed it had taken on roughly ₹300 crore in debt and said it is now comfortable borrowing for expansion.Ganesh Housing's land bank is real, but so is the new debt and the broken promises.
-
Gujarat Gas's Morbi volumes hit 0.36 MMSCMD in March. Management had guided 3-3.2.
The propane import strategy has flipped too. After insisting no capex was needed, management is now building its own jetty.
Inconsistency In January 2026, management assured investors that entering propane would require no capital investment, as they would use third-party port capacity. This quarter, they reversed course, stating they are actively evaluating building their own dedicated propane import jetty and storage tanks. The CGD capex guidance was also raised to ~₹1,000 cr from a ₹700 cr run-rate stated in January.Gujarat Gas's Morbi recovery is real, but the March miss and the propane strategy reversal make the forward guidance harder to trust.
-
Fiem promised a four-wheeler plan by May. Now it's delayed after the CEO left.
Management pledged the strategy twice. In June, it said the CEO departed and the plan will come 'shortly' with no new date.
Inconsistency In the Nov 2025 and Feb 2026 calls, Fiem management committed to presenting a detailed four-wheeler business plan and revenue impact by end of FY26 (May 2026). In June 2026, they postponed, citing CEO Vineet Sahni's departure and saying a strategy would come 'shortly'. Separately, management had said it would give direction on a dedicated greenfield plant by year-end. They now say no greenfield is envisaged and the ₹200 cr capex plan covers everything.Fiem's LED business is firing, but the four-wheeler strategy is a promise management has now missed twice.
Call-monitor notes
-
Aeron Composite navigates resin shock, targets 60-65% utilization in FY27
FY26 margins compressed to ~9% as styrene prices doubled; new owned facility, product mix shift and 300 crore revenue guide underpin recovery story
Aeron's resin shock is a reminder that external factors can hijack even a well-planned transition. The FY27 targets are credible if geopolitics cooperates.
-
Matrix Geo Solutions posts 81.5% revenue jump, but receivables cast a shadow
FY26 revenue surged to ₹40.1 crore, but receivables of ₹38 crore (95% of annual sales) expose 180-200 day government payment cycles. Management targets 70% collection this year.
Matrix Geo Solutions has the growth story; now it needs the cash cycle story.
-
Flywings Simulator's learning curve surges on new capacity
Mumbai facility opening and first-in-India helicopter simulator drive management's confident 20-30% FY27 growth guidance.
Flywings' lease-model moat is real, but FY27 guidance depends on Mumbai opening and helicopter ramp.
-
Timex India's license portfolio surges 10x, margins rise 600 bps
Revenue hits ₹800 cr, up 49% YoY, as Guess becomes India's largest licensed fashion brand and distribution productivity replaces outlet expansion.
Timex's license-led growth and margin gains are real, but capacity and channel risks cap the near-term upside.
-
CarTrade Tech launches Via AI and fintech push as next growth driver
Three-year financials show 29% revenue CAGR and margins rose from 9% to 33%; CEO positions fintech as 'day one of a long journey' with IDFC First Bank partnership live.
CarTrade's narrative is strong and its market is growing. Execution on fintech and AI will determine whether it's a story or a result.
-
Ducon Infratech sees ₹10,000 cr FGD pipeline, but revenue is two years out
Management confident in FGD order book, but operating income fluctuates with project cycles. Solar revenue starts only in FY25, hydrogen is distant.
Ducon's pipeline is strong, but revenue is two years out; execution lags behind the narrative.
-
VL Infraprojects diversifies beyond water; JJM restart fuels FY27 growth
MD Rajgopal Reddy outlined a plan to cut water infrastructure dependency from 80% to 30% over two years, adding railways, power, building, sewerage. Jal Jeevan Mission restart anchors FY27 inflection.
VL Infraprojects' diversification plan is ambitious; execution will determine whether the margin path holds.
-
NPST's margin dip is a mix story; CEO sees 70-80% growth from FY27
EBITDA margin fell 640 bps to 31% as TSP revenue swelled to 90% of total, pushing PPaaS to 5%. Management says the payoff comes in FY29.
NPST's margin sacrifice may be worth it if international and SaaS scale deliver as promised — but the receivables spike is a warning.
-
Yaap Digital targets 2% market share, setting ₹1,100-1,600 cr revenue goal in 3 years
The digital-first agency plans to quadruple revenue via tech integration, M&A, and cross-selling; management calls it a goal, not a projection.
Yaap's goal is audacious but credible; execution on tech, M&A, and client concentration will determine if it's a goal or a dream.
-
Twinkle Papers targets 40% CAGR after ₹6.5 cr capacity expansion
The plastic packaging maker is betting on a structural shift to plastic pallets, pre-booked orders and a 3,600-ton injection molding machine to drive growth.
Twinkle Papers' 40% growth target is ambitious but execution on debt reduction and customer concentration will define the outcome.
-
Adani Enterprises posts record ₹1.5 lakh cr capex, builds infrastructure empire
FY26 revenue up 7.4% to ₹2.92 lakh cr, PAT up 13.9%; net debt-to-EBITDA at 3.3x funds expansion into atomic, defense, and data centers.
Adani's infrastructure empire is a bet on India at a scale no private player has attempted. The numbers support the vision, but execution remains the deciding factor.
-
Q-Line's Unit 4 unlocks 3-4x capacity; reagents power margin renaissance
FY26 revenue ₹341.7 cr, EBITDA up 39% as manufactured reagents hit 70% of mix. CEO says no additional capex needed for growth.
Q-Line's reagent-led model is capital-light and margin-rich — the next milestone is activating dormant installations and proving exports.
-
Canara Bank asset quality improved sharply but NIM pressure capped profit growth
Gross NPA fell 110 bps to 1.84%, but net interest income was flat and NIM compressed 22 bps to 2.51% as deposit growth lagged credit expansion.
Good on bad loans, but core earnings remain under pressure from a deposit deficit that NIM guidance of 2.52-2.60% does little to resolve.
-
Ducon Infra's MD promises higher revenue in 2-4 years, but FY27 guidance stays vague
With Rs 20,000 crore CO2 capture allocation and a complete FGD portfolio, management sees a clear runway — but project lumpiness and working capital constraints keep near-term revenue flat.
Ducon's long-term story is attractive, but near-term investors are left to guess on timing.
-
Precision Camshafts rides ₹1,500 cr order book and EV breakthrough
Q4 profit surged 38% QoQ to ₹13.2 cr; EV platform with MOU for ₹60-70 cr annual revenue; raw material cost surge creates near-term margin pressure.
Precision Camshafts has the orders and the EV edge. Raw material headwinds are real but short-lived if pass-through works.
-
Suratwwala Business rides twin engines as land bank underpins long-term play
FY26 revenue scaled from Rs 11 cr to Rs 143 cr as real estate and solar platforms gain traction; 180-acre Pune land bank offers decade-long monetization runway.
Suratwwala has two credible platforms and a land bank that buys time. The next move is monetisation without margin sacrifice.
-
Shelter Pharma revenue jumps 44% as exports surge 164%
FY26 revenue hit Rs 73.13 crore on strong export and domestic expansion; EBITDA margin fell to 17% as spending on sales team and distribution weighed.
Shelter Pharma's revenue rocket is real, but margin recovery and working capital discipline are the next tests.
-
Jio IPO filed, FY26 records set, Reliance targets EBITDA doubling in five years
Consolidated revenue crosses ₹1,175,919 crore, EBITDA ₹207,911 crore, Jio Platforms files DRHP; management outlines five growth pathways.
Reliance is placing a big bet on Jio's IPO and New Energy. The numbers support the confidence, but execution is the multiplier.
-
Meta Infotech bets on margin discipline, targets 4x PAT growth by FY29
FY26 revenue rose 23% to ₹270 cr but PAT fell to ₹11 cr; management invested in talent and vendors, building a foundation for a 10-15% PAT margin goal.
Meta Infotech is building the service engine for the next five years, not the quarter. Watch the margin trajectory above the revenue line.
-
PG Health's gummies drove a goldrush quarter with 30% PAT growth
Livogen Iron Gummies topped Amazon rankings and helped flagship brands Neurobion and Livogen grow 20% each, as preventive health trend accelerates.
PG Health's gummy-led innovation is delivering growth and profit improvement, but the preventive health tailwind is not without competition.
-
Vilas Transcore triples CRGO capacity to 36,000 MT, targets ₹750 cr FY26 revenue
Unit 3 commissioned; radiators and nano-crystalline add margin lift even as CRGO price drop pressures near-term profitability.
Vilas Transcore's capacity surge is real; margin trajectory now depends on product mix and PGCIL unlock.
-
Nykaa unveiled a detailed FY30 roadmap targeting 2.5-5x revenue growth across verticals
FY26 consolidated revenue hit ₹10,000 cr with EBITDA at 7.2%; management guided for early-to-mid-teens EBITDA margin and 40%+ ROCE by FY30.
Nykaa’s multi-year guidance is ambitious but grounded in current numbers. Execution on AI and margin improvement will decide if the rocket lifts off.
-
E2E Rail’s platform strategy targets product-led revenue inflection
Nova Raksha platform and Kavach 4.0 progress underpin 40-50% growth guidance, but PAT margin stays at 5% through a three-year transition.
E2E Rail's platform-first bet on Kavach creates a product margin story the market has not yet priced.
-
Megatherm Induction's transformer unit at full capacity, stops fresh orders
Order book doubled to ₹80-90 cr; FY27 turnover target of ₹450+ cr set. PAT margins compressed to 6-7% on growth spending, but 17-18% EBITDA targeted in 2-3 years.
Megatherm has the order book and capacity constraint it wanted. The trick is turning those into margins, not just revenue.
-
E Factor pivots from events to IP ownership, targets ₹100 cr valuation for Shiva Immersive
The company invested ₹15-16 cr in proprietary content and aims for the IP to exceed ₹100 cr in value by next year, marking a structural shift from transactional execution to recurring asset-based revenue.
E Factor is selling an IP-driven future. The revenue guidance is believable; the valuation target is a bet on repeatability.
-
Redington targets $5B revenue by FY29 with platform-led orchestration
SSG revenue hit $2.2B, up 29% YoY; management outlines 3-year plan to double revenue and lift gross margins to 5.5-6% through software, cloud, and services.
Redington's transformation is well-mapped; the question is whether it can execute the services scale-up without diluting margins.
-
Systematic Industries' first Power Grid OPGW order opens ₹1,000 crore pipeline
First EPC contract from Power Grid launches new-age OPGW and OFC businesses; management targets accelerated growth post-IPO while legacy steel wire provides stable baseline.
Systematic's first OPGW order is a milestone, not a breakout. The pipeline is promising; execution is now the variable.
-
Gillette India rides profit juggernaut with 600 bps margin gain
FY26 PAT rises 23% to ₹650 cr as premium launches Guard 3-in-1 and Trimmers drive volume; management stays cautious on commodity inflation and rural demand.
Gillette India's profit juggernaut rolls on, but commodity and rural headwinds mean the next few quarters will test whether margin gains hold.
-
Dhara Rail's direct bidding pivot drives order book and margin surge
95% of ₹184 cr order book is now direct contracts, up from OEM-dependent model pre-IPO, lifting PAT to ₹15.4 cr, double the prior year.
Dhara Rail's direct bidding pivot is paying off in margins and orders, but the payment cycle keeps cash flow in check.
-
Wise Travel India bets on fleet expansion to nearly double EBITDA margins in FY27
Revenue surged 51% to ₹826 crore but PAT grew only 26% as accelerated depreciation from 795 new vehicles weighed. Management targets 22-25% EBITDA margin, more than double the 11.9% reported.
Wise Travel's guidance implies a step-change in margins. The numbers say it's possible on paper. The execution will say whether it's real.
-
Gurunanak Agricultur bets on harvester breakout to 500 units by FY29
After five years of stagnant thresher sales, management outlines a harvester-led pivot targeting Rs 10 cr revenue in FY27 and 500-unit annual run-rate by FY29.
Gurunanak's harvester pivot shifts margins from 20% to 35-40%. The 500-unit target is the bet; execution is the proof.
-
Karbonsteel Engineer orders surge 75%, guides for margin recovery
Production volume rose 22% to 34,900 tons in FY25; management sees normalized EBITDA margin of 12-13% in FY26 as capacity expansion and automation kick in.
Karbonsteel's order book and capacity investments give its margin targets weight, but the volume ramp remains the key variable.
-
RACL Geartech secures premium customers, targets ₹565 cr in FY27
New wins from Royal Enfield, Kawasaki, BMW and ZF drive a premium inflection; management guides for 20% sustainable growth while investing ₹77 cr in capex.
RACL Geartech's premium pivot is promising, but execution on multiple new projects will test its capital-light discipline.
-
Afcom locks in nine-freighter fleet, funding done
FY26 revenue ₹587.72 cr, up 143.86% YoY; PAT ₹121.90 cr, up 230%. Management targets minimum revenue doubling in FY27, backed by four Boeing 777s already financed.
Afcom's war bet is fully financed. The question is how long the tailwind lasts.
-
PAN HR's deployment surge and post-IPO cash power growth push
H2 FY26 revenue jumped 28% on 11,000+ workforce; debt-free with ₹2,434 lakh cash, management targets ₹1,000 cr by FY29 through 3PL, geography, and service mix expansion.
PAN HR's post-IPO balance sheet gives it the firepower to chase a ₹1,000 cr target. The deployment surge supports the ambition, but execution on 3PL and service mix will determine the margin journey.
-
Srigee says it lost 3-4 months to a factory move. It still wants to double revenue next year.
The capex-heavy electronics contract manufacturer is guiding ₹100 cr in FY27 from ₹72 cr this year, but a facility transition ate into two quarters and polymer prices tripled in March.
Srigee's FY27 guidance is a promise to double revenue during a factory move. August will tell if it's a plan or a hope.
-
Srivasavi Adhesive's margin squeeze is the price of its ambition
FY26 revenue grew 22% but PAT fell as ₹17 cr capex left new units running at 50% capacity. Management wants double-digit margins in FY27.
Srivasavi's margin pain is the cost of buying a seat at the institutional table. The bet is on credentials; the bill is due now.
-
Greenleaf wants to own water infrastructure, not just build it
The ₹60.6 cr wastewater EPC specialist is pivoting to recurring-revenue CETP projects, betting on 25-30 year lifecycles to change its business model.
Greenleaf's EPC margins are fine today. The CETP bet is whether 'fine' becomes 'recurring'.
-
Rulka Electricals is chasing ₹50-70 cr orders. Last year it did ₹15-20 cr jobs.
The MEP contractor slashed debt 45% and turned cash flow positive, but the big-order pivot needs a bigger balance sheet.
Rulka's balance sheet is finally clean. The next chapter is about whether it can stay that way while chasing jobs five times larger.
-
Utkal Speciality's IPO is a bet on a ₹9.59 cr aluminum capex it hasn't built yet
The paper packaging maker's listing hinges on a new aluminum containers facility it says will start in March 2025.
A margin-efficient paper packager is listing, but the price tag assumes an aluminum future that's still a construction site.
-
Abha Power & Steel's molding automation aims to lift utilization from 20% to 90% by August
H2 revenue fell 25% on a 20% insert price crash, but management is betting on automated casting and long-term OEM contracts for a margin recovery to 15-20%.
Abha's cycle is bottoming, but its turnaround is a capex bet that has to hit its August deadline.
-
Exim Routes sets Rs 300 cr revenue target for FY27 after 72% growth in its first listed year
Core trading margin rose 300bps to 22.4%, but reported EBITDA margin compressed to 6.8% on freight headwinds.
The core trading machine works, but the platform story is still a promise on a PowerPoint.
-
Yaap Digital's profit growth doubled, but cash flow turned negative
FY26 revenue grew 22.2% and EBITDA surged 89.1%, yet operating cash flow was negative — a contradiction the call didn't resolve.
Yaap Digital's profit growth is real, but the cash flow deficit is a warning sign that the 2% market share dream needs a better financing plan.
-
Felix Industries guides ₹180-200 cr revenue for FY27, tripling from ₹102 cr
MD Ritesh Patel puts a ₹100-150 cr ceiling on the Mehsana recycling facility alone, as three expansion bets hit simultaneously.
Tripled once, guiding to double again. Felix now has to prove three ramp-ups work at the same time.
-
Dhansa Labs bets ₹150 cr on green energy while its core margins compress
A ₹30 cr atrazine capex and ₹120 cr CBG project anchor a 20% FY27 growth guide, but working capital and margin pressure are the immediate headwinds.
Dhansa's agrochemical core needs to generate the cash flow before the green energy bets can pay off.
-
Apsis Aerocom targets Rs 500 cr revenue in five years as order book grows 69%
Unit 2 capacity expansion powers FY27 guidance of Rs 48 crore, with defense segment anchoring 65% of FY26 revenue
The demand is real, but Apsis must prove it can build capacity as fast as it can win orders.
-
Nanta Tech guides for 50% revenue growth as robotics-AI mix targets 60-65% of FY27
H2 EBITDA margins hit 17.3% on 400 robot deployments, but the AV working-capital cycle remains the open question.
Nanta's 50% growth guide is a bet that the robotics-AI pivot can outrun the working-capital drag of its legacy business.
-
Wockhardt's Zaynic launch is its biggest bet since founding. It won't be quick.
FDA approval for the first Indian-discovered antibiotic is a 25-year milestone. But the US commercial ramp is a hockey stick, and breakeven is 12-18 months away.
Wockhardt's Zaynic approval is the proof. The hard work of building the market starts now.
-
Shri Balaji Valve wins German customers but warns raw material prices are slowing orders
FY26 revenue rose 19.5% to ₹96.80 cr and management guides 20-25% growth for FY27, but near-term conversion is stalling on raw material cost volatility.
Shri Balaji's German traction is real but raw material noise is drowning out the signal.
-
Highness Microelectronics guides for 85-100% revenue growth in FY27 on defense and railways push
CEO Gaurav Kejriwal is targeting ₹100 cr revenue in four years, but first he needs to ramp a Goa factory and land more orders.
Highness has the guidance, the margins, and the target market. Now it needs to build the factory and prove the orders are real.
-
Greenlam's new businesses are bleeding, but laminates carry the quarter
Chipboard and plywood losses narrowed sharply in Q4, with both units now targeting break-even in FY27.
Greenlam's laminates are carrying the P&L; the question is how long management can ask them to.
-
Signpost India's receivables surged 80% even as profits tripled
The out-of-home ad company's Q4 EBITDA grew 3x, but a spike in receivables from multi-city campaigns forced a billing model change
Signpost India's profit story is solid, but the receivables spike means the cash story is what matters next.
-
Bata's volume acceleration is real, but margin recovery isn't yet
Second consecutive quarter of volume-led growth and 28% inventory reduction over two years, yet reported PBT fell 94% on plant-closure and FX charges.
Bata's operational fixes are working, but the margin recovery it needs is still a quarter or two away.
-
TCPL says it's passing through costs. It also says it's losing money when it does.
Double-digit domestic volume growth is absorbing export pain, but a drip of raw material inflation is compressing margins faster than pricing can catch up.
TCPL is growing volumes through an inflationary squeeze, but margins are hostage to how fast costs rise and how slowly customers pay.
-
ABS Marine's fleet expansion is printing money. The real question is how much longer the boom lasts.
FY26 EBITDA surged 179% to ₹152.55 cr on a 47% margin, driven by a shift to higher-rate L&T and EPC charters and a fleet bought at deep discounts.
ABS Marine is riding the offshore cycle well, but the premium it now trades at requires the boom to last.
-
TBI Corn completes capacity expansion, sees muted profit upside from big customers
New Malkapur plant and Mumbai export unit are online. Volume growth hit 44%, but the 5-9% margin band with ITC and peers limits near-term profit gains.
TBI Corn built the capacity. The profit gains will have to come from exports and germ yield, not its biggest domestic customers.
-
United Heat Transfer eyes ₹15-20 cr Vertiv data center business as Western brands pivot to India
A trial order for specialized CDU components is in validation with a 2-3 month approval window, and management sees ₹15-20 cr annual potential once approved.
The Vertiv trial is a ₹10 lakh order with a ₹15-20 cr promise. The next quarter tells you if the promise is real.
-
Virtual Galaxy targets 40% CAGR, pins hope on 350 new NBFC customers
Core banking platform vendor reports 52% revenue growth to ₹182 cr and guides for 40% CAGR through FY29, with RBI's NBFC rules opening a new regulatory-driven market.
The NBFC regulatory push is a real TAM, but Virtual Galaxy is still selling the sizzle; the steak arrives in FY28-29.
-
Current Infra guides ₹250 cr revenue for FY27, up 55% on a ₹328 cr order book
Solar EPC shifts to 10-30 MW project sizes and wraps its entire FY27 portfolio in government contracts with price escalation clauses.
The guidance is ambitious and well-supported on paper; the FY27 outcome hinges on a single ₹100 crore order executing on time.
-
WOL 3D India triples e-commerce revenue but compresses margins to chase market share
FY26 revenue doubled to ₹98 cr as printer volumes nearly hit 20,000 units, but gross margins fell ~4% as the company spent on team, facilities and influencers to build demand.
WOL 3D is spending to own a market barely 0.3% of global size. The bet is big, the margin hit is now.
-
Osel Devices targets ₹500+ cr revenue in FY27, betting on hearing-aid retail and SaaS
A 3-4x hearing-aid margin uplift via retail, a 1,800-branch bank SaaS deal and an export doubling define the triple-engine growth thesis.
Osel's triple-engine pitch has the right structure but too many unquantified parts to underwrite the 70% growth it implies.
-
Hardwyn's ₹1,000 crore target by FY32 implies a 10x jump from ₹91 crore
MD Rubaljit Singh Sayal calls it 'ambitious yet achievable' on the back of a manufacturing shift, dealer expansion, and new export markets.
Hardwyn's manufacturing shift is real, but a 10x revenue jump in six years asks a lot of a new export and digital business.
-
Adisoft hit a capacity ceiling at ₹169 cr. A new plant targets ₹650-700 cr.
FY26 grew 26.7% but management said it could not take more work. The Bhosari facility is meant to change that.
The old plant is full. The new plant is a promise. The customer base is still one.
-
Cash UR Drive targets 50-50 exclusive-to-traded media split within three years
Exclusive media is now 32% of revenue at ₹60 cr, carrying roughly double the margin of traded media. Utilization sits at 55%.
Cash UR Drive's exclusive-media pivot is producing profit gains, but the cash-flow math gets harder before it gets easier.
-
Indian Emulsifiers missed its margin guidance, but the real problem is the rights issue math
Revenue grew 57% to ₹160 cr, but EBITDA margin fell to 16.4% versus an 18-22% guide. Now it wants shareholders to fund a ₹51 cr raise when the company is worth ₹75 cr.
Growth at Indian Emulsifiers is real. The price shareholders are being asked to pay for it is getting steep.
From the earnings calls
Summarised straight from the company's earnings-call transcript, same day. We cite the call and link the transcript; we don't reproduce it.
-
MobiKwik posts Q4 profit, invests in merchant growth engines
Core payments and lending are profitable, but reinvestment into merchant payments will keep near-term margins modest.
-
Aurionpro misses Q4 targets on MEA war, hyperscaler delay; CEO vows resilience
A disappointing quarter with costly missteps, but medium-term drivers remain intact.
-
Dixon sees near-term margin pressure but bets on Vivo, IT hardware ramp
Near-term headwinds from PLI sunset and memory inflation will pressure margins, but backward integration and new verticals provide long-term growth runway.
-
Nexus Select Trust targets 9% DPU growth in FY27 on strong demand
Management conservatively guided 9% DPU growth but sees upside from consumption and leasing spreads.
-
V-Guard Q4 revenue up 14%, PAT up 23%; cost inflation a concern
Strong Q4 performance masks brewing commodity cost pressure from West Asia war; management is confident on margin resilience but cautious near-term.
-
Neuland Labs posts record Q4 but flags lumpiness ahead
A stunning quarter, but management warns the 40%+ EBITDA margin is not a new normal; lumpy growth is the reality.
-
Berger Paints expects volume growth to hold as price hikes offset inflation
Proactive pricing and cost control keep margins in guided band despite input inflation
-
Tata Power posts record PAT above Rs 5,000 crore in FY26, eyes 25,000 crore capex in FY27
A record year across all segments, but renewable execution and transmission delays remain the key watchpoints.
-
Sagility posts strong Q4, guides for low double-digit growth in FY27
Strong execution and seasonal tailwinds drove a beat, but FY27 guidance reflects cautious optimism amid AI headwinds.
-
Dr. Reddy's Q4 hit by ₹453cr lenalidomide hit, but base business grows double-digit
Management struck a cautiously optimistic tone, citing strong base business momentum and semaglutide approvals, but the massive lenalidomide shelf-stock adjustment blindsided analysts.
-
FirstCry expects FY27 growth to outpace FY26 as delivery initiatives gain traction
Management's delivery and offline bets are paying off, but diaper margin wars remain a drag.
-
Zuari Industries sees debt halving to ~₹700-800cr as Dubai project cash flows in
The sugar and ethanol beat is overshadowed by the real progress on deleveraging — the Dubai payoff is finally in sight.
-
Aarti Pharmalabs expects 15-18% revenue, EBITDA growth; CDMO to lead with 40-50% jump in FY27
Management's growth guidance hinges on CDMO ramp-up and Xanthine capacity addition, but margin headwinds from raw material inflation persist.
-
Orchid Pharma sees pricing recovery, targets 12% EBITDA margin for FY27
Worst of cephalosporin pricing cycle may be behind, but execution on new platforms remains key.
-
Amara Raja Q4 revenue up 16% but margins hit by raw material costs
Strong revenue growth tempered by cost pressures and muted exports, with margin recovery hinging on further price hikes.
-
Aia Engineering posts record profit but future hinges on mining solution scale-up
Record earnings from currency and mix, but the mining solution breakthrough remains a promise, not a pipeline.
-
Jubilant Ingrevia posts best quarterly revenue in 14 quarters, flags growth acceleration ahead
A solid quarter with strong execution, but CDMO ramp-up and agro recovery are critical for sustained 20% EBITDA growth.
-
Camlin Fine maintains FY27 guidance despite geopolitical headwinds
Management held firm on double-digit EBITDA margin guidance despite a sharp Q4 hit from shipping disruptions and raw material inflation, betting on vanillin and blends growth.
-
Cosmic CRF wins Supreme Court nod for Amazon, Q4 revenue jumps 78%
Supreme Court clearance for Amazon acquisition is the game-changer, but execution and RDSO license delays remain risks.
-
Rupa & Company sees volume-driven growth, guides to 9-10% EBITDA margin
Athleisure rebound and price hikes boost margins but competitive pressures persist.
-
Salzer Electronics targets 9.5% EBITDA margin in FY27 after commodity cost pressures
Management's margin recovery hinges on price hikes passing through, but execution risks remain.